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Abstract 
Background: Anorexia Nervosa (AN) is a severe and potentially deadly disorder 
that is often found to be resistant to treatment, especially in adult populations. Patients 
commonly present a strong ambivalence towards recovery and high rates of premature 
treatment termination. The working alliance has been found to be a strong predictor of 
treatment outcome across an array of psychological disorders and treatment approaches; 
however, little research has been conducted to understand its role in the treatment of AN 
and its relation to motivation for treatment or outcome in this population. The present 
pilot study sought to investigate primarily the associations between reports of working 
alliance, measurements of motivation for treatment, and AN treatment outcome. This is 
the first study to examine the relation between motivation and working alliance in AN 
patients. Method: The present study was a secondary analysis of data obtained from a 
sample of 53 adult AN patients who were admitted to a specialized inpatient/day-hospital 
eating disorder treatment program. The patients completed self-report questionnaires 
measuring autonomous and controlled motivation for treatment at baseline and at week 
four, self-report questionnaires regarding working alliance at week four, and clinical 
symptomatology and BMI were measured at baseline, week four, and discharge. Results: 
Changes in Autonomous motivation for treatment from baseline to week four were found 
to predict working alliance scores at week four. No association was found between 
measures of motivation for treatment or working alliance with treatment outcome or rates 
of premature treatment termination. In exploratory analyses, AN subtype (i.e., restricting 
vs. binge-purge) was significantly associated with working alliance scores, measures of 
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treatment outcome, and rates of premature treatment termination. Conclusions: The 
results of this study point to the importance of early measurements of working alliance in 
this population and brings into question the validity of early self-reports of motivation in 
AN treatment. On balance, the present findings do not align with previous findings in the 
literature. Limitations of the current study related to high attrition and low statistical 
power are discussed. The differences observed between AN subtypes in their response to 
treatment add to a growing body of clinical knowledge that may suggest a need for 
researchers and clinicians to reformulate how these clinical subtypes are conceptualized.  
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Introduction 
The working alliance in psychotherapy has been the subject of considerable 
research over the past two decades, particularly in terms of its role as a predictor of 
treatment outcome for an array of different clinical populations and treatment approaches. 
A growing number of studies indicate that, when considering the large majority of 
psychotherapy approaches, the working alliance between patient and therapist is one of 
the strongest predictors of treatment outcome (Falkenström, Granström, & Holmqvist, 
2014; Horvath, Del Re, Fluckiger, & Symonds, 2011; Martin, Garske, & Davis, 2000). 
However, data suggests that this association could be influenced by factors such as the 
perspective of the rater, time at which measures of the working alliance are taken, 
improvements in presenting symptoms, as well as characteristics of the patient and the 
therapist (Elvins & Green, 2008; Horvath & Bedi, 2002; Martin, Garske, & Davis, 2000).  
 Working alliance may play a particularly key role in the treatment of eating 
disorders, and specifically anorexia nervosa (AN), as this population often demonstrates 
ambivalence about change and treatment non-adherence, likely due to the disorder’s 
egosyntonic features (Hay, Touyz, & Sud, 2012; Starzomska, 2009). Current 
understanding of the nature of the working alliance and its relationship with AN 
treatment outcome is hindered by the very limited number of studies conducted on this 
topic to date (Zaitsoff, Pullmer, Cyr, & Aime, 2015). In addition, the subject is presently 
a source of debate amongst researchers (Zaitsoff, et al., 2015). Given the severe health 
risks inherent to AN and the frequently poor treatment outcomes associated with the 
disorder, particularly in adult populations, it is imperative to improve the effectiveness of 
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existing treatment approaches. One way to achieve this may be to increase clinical 
understanding of the function of the working alliance within an adult population with AN 
receiving specialized treatment. An improved understanding of the factors associated 
with the working alliance as well as its relationship with treatment outcome can inform 
the development of more effective evidence-based, best-practice interventions for AN. 
The present dissertation attempts to shed light on this matter by analyzing data pertaining 
to these treatment factors gathered in a hospital-based specialized hybrid inpatient/day-
treatment program for adults with AN. 
Review of the Literature 
Theoretical and Historical Background of the Working Alliance 
 The Working Alliance is a summary term that describes the relationship bond that 
can develop between the patient and therapist through mutual trust and collaborative 
work in establishing and reaching treatment goals (Constantino, Arnow, Blasey, & Agras, 
2005). The working alliance is also known throughout the literature as "working 
relationship", "therapeutic alliance", and "therapeutic relationship" (Horvath, et al., 2011; 
Oyer, 2014). The concept of the relationship between patient and therapist being an 
active therapeutic ingredient in the treatment process has been a theme of psychology as a 
discipline for over a century (Elvins & Green, 2008; Horvath et al., 2011). For instance, 
Freud (1912) described transference and countertransference as important elements for 
change to occur in psychoanalysis and believed that the supportive stance of the therapist 
allows for positive transference. From a humanistic psychology perspective, Rogers 
(1965) highlighted the therapist’s empathy as experienced from the perspective of the 
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patient. Greenson (1965) endorsed the concept that the relationship between therapist and 
patient was an essential aspect of successful treatment, emphasising and elaborating on 
the active aspect of this collaboration. However, the working alliance is commonly 
understood in the literature as a construct that was crystallized in the work of Bordin 
(1979) and much of the current research on alliance is based on the framework he 
proposed.  
Bordin (1979) described the concept of working alliance as composed of three 
main elements: agreement on the goals of therapy, agreement in the tasks of therapy, and 
the bond that develops between the therapist and the patient. For the first two elements, 
agreement on goals and tasks, the important characteristic is agreement, which is the 
understanding that both parties agree to work collaboratively, and in harmony, on agreed 
upon tasks and goals, providing a mutual motivation to work through the challenges of 
change. According to Bordin, the third element of the working alliance – the bond 
between therapist and patient – is developed through a congruence in pre-existing biases 
and expectations from each member of the dyad. Trust, liking, and attachment are 
developed over time as the psychotherapist and patient experience each other in session, 
thereby developing the quality and depth of the relationship. According to Bordin’s 
(1979) model, it could be hypothesized that deficiencies in the working alliance between 
patient and therapist would result in lower rates of treatment success and patient 
satisfaction as well as a higher risk of premature treatment termination. 
Bordin (1979) argued that the psychoanalytic concept of working alliance in 
therapy could be generalized to all psychotherapies in one way or another and that the 
WORKING ALLIANCE, MOTIVATION, AND ANOREXIA NERVOSA 
 
4 
 
strength of the working alliance, not the theoretical model of treatment, is one of the most 
important elements impacting the effectiveness of therapy. In addition, Bordin proposed 
that the development and impact of the working alliance occurs independently of the 
theoretical orientation in which a given psychological treatment is based. However, the 
particular treatment approach that is used will shape the way in which the working 
alliance forms and grows. Put differently, therapeutic objectives and procedures are 
variables which are based on the particular training orientation of the professional and the 
preferences of the patient. As such, they would be expected to change from dyad to dyad. 
While the early formulations of the working alliance concept are rooted in 
psychoanalytic therapy, it has become an intricate element of the very diverse forms of 
psychotherapies currently available. For example, within the paradigm of CBT, the 
original authors of the approach emphasized the importance of working collaboratively 
with the patient to generate goals, plans, and conceptualizations (Beck et al., 1979). One 
of the key elements in CBT is the idea of practicing cognitive and behavioral changes. 
This allows the individual the experience of alternatives to pathological patterns of 
thinking and behaving. This practice, however, can only be undertaken by the patient 
through effort and patience. The individual is much more likely to make these efforts if 
the actions and goals are understood and accepted. Agreement on goals and tasks in CBT 
is developed through what authors call "collaborative empiricism" (Dobson & Dobson, 
2013; Kazantzis, Tee, Dattilio, & Dobson, 2013). This term refers to the partnership 
between clinician and patient in the development of the topics and possible experiences 
that will be part of a given therapeutic process. Dobson and Dobson (2013) further argue 
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that therapeutic techniques need to be adapted and tailored to the cultural background and 
particular preferences of the individual patient in order to maximize patient engagement 
and adherence to therapy, and that this process is facilitated by the inclusion of the patient 
in the generation of therapy themes. Wong (2013) demonstrated this point by discussing 
the need to adjust the language and delivery of information and techniques working with 
Chinese patients. For example, the author mentions drawing parallels between the 
teachings of Confucius and the idea of empiricism to increase the working alliance in his 
work with patients from this population. 
Working Alliance Measures  
Numerous psychometric instruments have been developed in an effort to measure 
the construct of working alliance with varying underlying theoretical conceptualizations 
being used to create different scales (Elvins & Green, 2008). Over 30 different working 
alliance measures have been developed to date and, due to the diverse theoretical models 
on which these measures have been based, many scales share certain common elements, 
but lack a singular point of reference (Horvath et al., 2011) with different instruments 
emphasizing different aspects of the working alliance (Horvath & Bedi, 2002). However,   
The measures most frequently employed to assess working alliance in the 
research literature include the Helping Alliance Questionnaires (HAq; Luborsky, 
McLellan, Woody, O'Brien, & Auerbach, 1985), the Vanderbilt Psychotherapy Process 
scales (VPPS/VTAS; Suh, Strupp, & O’Malley, 1986), the California Psychotherapy 
Alliance Scale (CALPAS; Gaston & Marmar, 1994), and the Working Alliance 
Inventories (WAI; Horvath, 1981, Horvath & Greenberg, 1989). Tichenor and Hill 
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(1989) found that these measures had strong internal consistency, with the exception of 
the HAq, which was not included in their analysis. Horvath et al. (2011) reported that 
these four measures were utilized in 2/3 of all the data they collected in their meta-
analysis of the relationship between working alliance and treatment outcome. In an 
analysis of common instruments employed to assess the working alliance it was found 
that instrument effects had little statistical impact on the relationship between working 
alliance and treatment outcome overall (Horvath, 2001). However, of the available 
measures, the WAI has been used in the greatest number of studies that assessed the 
working alliance and outcome (Elvins & Green, 2008; Martin et al., 2000). The WAI is 
based on the tripartite model proposed by Bordin including agreement on tasks, goals, 
and therapeutic bond and, unlike many other psychometric instruments, the WAI evolved 
from a transtheoretical perspective and was developed specifically to allow for 
measurement of the working alliance in any form of therapy for any disorder 
(Castonguay, Constantino, Holtforth, & Grosse, 2006). Of all working alliance measures, 
the WAI is one of two scales to have received the greatest amount of construct validation 
(Elvins & Green, 2008) and it has three versions, which allow for measures of the 
working alliance to be taken from different perspectives; patient, therapist, and/or 
independent observer.  
Tichenor and Hill (1989) demonstrated that WAI scores obtained from the three 
types of raters may not correlate with each other, although the authors noted that these 
results were found in a rather small sample (N=8). While all three types of rater have 
demonstrated reliability in predicting treatment outcome (Martin et al., 2000), studies 
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suggest that, regardless of therapeutic approach, scores in the patient version of measures 
such as the WAI show a higher correlation with scores on outcome measures than either 
clinician versions (Elvins & Green, 2008; Horvath & Symonds, 1991; Horvath & 
Luborsky, 1993) or independent observer reports (Martin et al., 2000). A possible 
explanation for these differences could be that reports by clinicians and independent 
observers are unable to directly account for the inner experiences and motivations of the 
patients that influence the working alliance. Horvath and Symonds (1991) suggested that 
a clinician's inaccurate estimation of the working alliance could lead to ill-timed 
interventions, which can have a negative impact on the course of therapy. The authors 
argue that the patient's rating of working alliance could be a more valid construct than its 
therapist counterpart. These observations suggest that, while the working alliance is 
developed and experienced by two individuals (or more, in the case of treatment teams), 
the perception of the patient may be most important in predicting treatment outcome.  
Given that the working alliance has the potential to fluctuate throughout the 
course of treatment, even from session to session, the stage of treatment in which the 
measure is taken could have an effect on the results (Martin et al., 2000). One meta-
analysis found that late-treatment measures of the working alliance may be a better 
predictor of treatment outcome, although the authors noted that these results should be 
considered with caution as they could be influenced by later improvements in 
symptomatology rather than gains in working alliance (Horvath, 2001). Other studies 
have indicated that measures taken as early as the first session are more indicative of 
treatment outcome (Martin et al., 2000). Horvath (2001) concluded that early measures of 
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alliance (in the first third of treatment or between sessions 1 through 5) where slightly 
more predictive of treatment outcome than mid-session measures. This suggests that 
developing a strong working alliance early on in the therapeutic process may therefore be 
important in order to ensure better treatment outcome. 
Working Alliance and Treatment Outcome  
The role of working alliance in the therapeutic process and its relationship with 
treatment outcome have been the focus of substantial research. Numerous large-scale 
clinical trials have been undertaken to assess the relationship between the two and a large 
body of work supports the hypothesis that the working alliance predicts treatment 
outcome (Castonguay et al., 2006). For example, Krupnick et al. (1996) found that the 
working alliance was strongly predictive of outcome in 225 participants diagnosed with 
major depressive disorder who received either interpersonal psychotherapy, cognitive-
behaviour therapy, pharmacotherapy, or placebo with clinical management. Moreover, 
the relationship between working alliance and treatment outcome was constant across 
modalities and a greater percentage of the variance in outcome was attributable to 
alliance than to treatment approach (Krupnick et al., 1996).  
A number of meta-analyses have examined the relationship between working 
alliance and treatment outcome across different clinical populations and treatments. For 
example, in their meta-analysis of the relationship between working alliance and 
treatment outcome across a variety of disorders and treatment approaches, Martin et al. 
(2000) reported that the effect of working alliance on outcome showed a moderate effect 
size. They also found that the strength of this relationship remained stable even after 
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controlling for other hypothesised confounding variables, including variability in 
outcome measures and type of rater used. In another meta-analysis that identified over 
200 relevant studies, Horvath et al. (2011) similarly found that working alliance had a 
moderate positive association with diverse measures of outcome across different 
disorders, acting as one of the strongest predictors of successful therapeutic outcome. In 
addition, one meta-analysis of 11 studies of adult psychotherapy found a moderately 
strong correlation between lower levels of working alliance and increased likelihood of 
treatment attrition (Sharf, Primavera, & Diener, 2010).    
While research indicates that the working alliance plays an important role in the 
therapeutic process and is consistently predictive of treatment outcome, some theorists 
suggest that other aspects of psychotherapy, such as early symptom change, may have a 
greater direct influence on treatment outcome than working alliance (Feeley, DeRubeis, 
& Gelfland, 1999). However, a number of studies have also indicated that working 
alliance remains a significant predictor of treatment outcome after factoring out these 
confounding variables (Flückiger, Del Re, Wampold, Symonds, & Horvath, 2012; Klein 
et al., 2003). For example, in a large study of working alliance and primary care in the 
treatment of a number of different psychological disorders including anxiety and 
depression, Falkenstrom, Granstrom, and Holmqvist (2014) found that early symptom 
changes did not predict subsequent improvements in working alliance measures. Other 
investigations of the working alliance, early symptom improvement, and the role these 
factors play in predicting treatment outcome have suggested that another type of 
interaction could be at play. For example, Xu and Tracey (2015) examined working 
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alliance and early symptom improvement in the treatment of 638 community patients 
treated for a variety of mental health issues. Through a longitudinal assessment, the 
researchers found that working alliance and symptomatic recovery might in fact work 
reciprocally over the course of therapy, and that their interaction appeared to be a 
stronger predictor of overall treatment outcome than either factor by itself. However, 
other studies have reported contradictory findings. For example, in an investigation of the 
working alliance and outcome in binge-eating disorder, Tasca, Compare, Zarbo, and 
Brugnera (2016) found that increases in working alliance predicted subsequent decreases 
in binge-eating episodes, but that decreases in binge-eating symptoms did not predict 
improvements in working alliance. 
Some studies suggest that certain pre-treatment factors may influence the 
development of the working alliance, although results have been varied. Patterson, Uhlin, 
and Anderson (2008) conducted an analysis of patient baseline characteristics as 
predictors of working alliance ratings by the third session of treatment in a sample of 57 
university counselling patients. The authors found that presenting a personal commitment 
to therapy at baseline was highly correlated with all three aspects of the working alliance 
(goals, tasks, and bond) and that this predicted alliance ratings three sessions into therapy 
as measured by a revised, short form of the WAI (Patterson, Uhlin, & Anderson, 2008). 
Similarly, Castonguay et al. (2006) highlighted in their literature review that a patient's 
optimistic expectation for change is positively correlated with working alliance ratings, 
while patient avoidance and interpersonal difficulties are negatively correlated with 
working alliance. More recently, it has been suggested that the patient’s ability to create 
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positive relationships could also be a factor that contributes to the development of the 
working alliance (Zilcha-Mano, 2017). Therefore, development of the working alliance 
and subsequent treatment outcome could be at least partly dependent on the patient's self-
motivated decision to dedicate the required effort throughout the therapy process as well 
as their own interpersonal skills. Other researchers have investigated whether or not pre-
treatment severity of symptoms impedes the ability of individuals to develop a healthy 
working alliance, however this relationship has not been clearly established as there have 
been inconsistent findings. Some studies have found that greater baseline symptom 
severity is not associated with weaker working alliance (Joyce and Piper, 1998), while 
other studies have found that greater symptom severity predicts lower levels of working 
alliance (Zaitsoff, Doyle, Hoste, &, le Grange, 2008).  
In addition, although patients might possess certain traits that could affect the 
formation of the working alliance, characteristics of the therapist likely also impact its 
development (Castonguay et al., 2006). Elvins and Green (2008) reported that particular 
therapist attributes and techniques, such as the ability to adapt easily and the possession 
of a warm demeanor, contribute to the formation of a strong working alliance. The 
therapist’s ability to address ruptures in the alliance and to use these occasions to explore 
negative emotions that the patient experiences could also lead to positive gains in the 
working alliance while therapist avoidance would have a negative impact (Rainer & 
Campbell, 2001). 
In summary, considerable research has been conducted on the working alliance 
developed between patient and therapist and its role as a predictor of treatment outcome. 
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There is some evidence that certain factors, such as patient and therapist traits, 
improvements in presenting symptoms, as well as the time point during therapy at which 
working alliance is measured may influence the relationship between working alliance 
and treatment outcome. Nevertheless, the working alliance remains one of the strongest 
predictors of treatment outcome across a diverse range of clinical populations and 
psychological treatment approaches. Thus, it is perhaps surprising that few studies to date 
have examined the relationship between working alliance and treatment outcomes in the 
treatment of anorexia nervosa (AN) particularly considering that treatment outcome in 
AN is often poor, with high rates of treatment drop-out and relapse. To address this gap, 
the relationship between working alliance and treatment outcome in adults with AN will 
be the focus of the current investigation. In the next sections, a description of the clinical 
features of AN will be presented followed by a summary of the treatment outcome 
research on AN to date, as well as the research thus far on the relationship between 
working alliance and treatment outcome in AN. 
Anorexia Nervosa 
 Anorexia Nervosa (AN) is an eating disorder characterized by obsessive concern 
about weight, low body weight, a strong desire to be thin and/or fear of gaining weight 
despite being underweight, and behaviours aimed at decreasing body weight (American 
Psychiatric Association [APA], 2013). The 5th Edition of the Diagnostic and Statistical 
Manual (APA, 2013) outlines three main criteria for a diagnosis of AN that describe 
behavioural, cognitive, and perceptual factors that deviate from healthy food 
consumption and self-appraisal: Criterion A:  "Restriction of energy intake relative to 
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requirements, leading to a significantly low body weight in the context of age, sex, 
developmental trajectory, and physical health". The DSM 5 clarifies that significantly 
low weight for adults refers to "weight that is less than minimally normal"; Criterion B: 
"Intense fear of gaining weight or of becoming fat, or persistent behavior that interferes 
with weight gain, even though at a significant low weight"; and Criterion C: "Disturbance 
in the way in which one's body weight or shape is experienced, undue influence of body 
weight or shape on self-evaluation, or persistent lack of recognition of the seriousness of 
the current low body weight" (APA, 2013).  
 The diagnosis is conceptualized with four possible levels of severity, based on the 
individual's Body Mass Index (BMI), which is calculated by dividing the individual's 
weight in kilograms by the square of their height in meters. A healthy BMI ranges 
between 18.5 and 24.9 kg/m
2
. Therefore, a BMI of less than 18.54 or below is required to 
meet Criterion A of the DSM 5. The ranges of severity for AN are mild, with a BMI 
between 17 and 18.49 kg/m
2
; moderate, with a BMI between 16 and 16.99 kg/m
2
; severe, 
with a BMI between 15 and 15.99 kg/m
2
; and Extreme, with a BMI lower than 15 kg/m
2
 
(APA 2013). Using the BMI as a sole measurement of AN severity has been questioned 
given that BMI calculations within several populations, such as bodybuilders, pregnant or 
lactating mothers, and the elderly, might not yield valid results. The severity of the 
disorder can therefore also be impacted by the number and severity of clinical 
symptomatology or the extent to which these symptoms impair the individual's normal 
functioning. 
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 Two distinct subtypes of AN, restricting subtype (AN-R) and binge-
eating/purging subtype (AN-BP), have been repeatedly observed by clinicians and 
researchers. The two subtypes are classified in the DSM 5 within the AN diagnosis and 
are defined by differences in the behavioural presentation in Criterion A. Individuals 
diagnosed with the restricting subtype focus on minimizing or controlling food intake 
through dieting or fasting in order to achieve weight loss. Individuals within this subtype 
may also engage in a disproportionate amount of exercise in relation to the amount of 
food consumed in order to achieve an energy deficit.  In the binge-eating/purging 
subtype, in addition to the above symptoms, individuals also experience episodes of 
binge-eating and/or compensatory purging behaviour such as self-induced vomiting or 
the inappropriate use of diuretics or laxatives.  
The initial development of AN can be influenced or triggered by a multitude of 
different factors including cultural, biological, and psychological components. 
Sociocultural norms and pressures to conform to societal expectations of beauty and 
attractiveness in western culture, which praises slim bodies and thinness over other body 
types and endorses often unattainable body shapes (e.g., large breasts in combination 
with thin a body shape for women), could have an influence (Thompson & Heinberg, 
1999; Vitousek, Watson, & Wilson, 1998). Reports have also indicated that AN might 
entail biopsychosocial roots, pointing at familial or hereditary components (Kaye, 
Strober, Stein, & Gendall, 1999). The risk of developing AN is significantly increased in 
individuals who have a family member with AN (Machado, Gonçalves, Martins, Hoek, & 
Machado, 2014) and heritability estimates of AN range from 56-70% (Guarda, 2008). 
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Furthermore, certain personality traits seem common among individuals with AN and 
include perfectionism and rigidity, body shape-related anxiety, elevated harm avoidance 
(Kaye et al., 1999), and low self-esteem (Cervera et al., 2003). 
 The age of onset of AN peaks between mid- to later-adolescence, although new 
cases can still develop much later in life (APA, 2013; Lapid et al., 2010). The disorder is 
most often seen in females rather than males and in Caucasian individuals more often 
than in other ethnicities (APA, 2013; Hoek, 2006; Hudson, Hiripi, Pope, & Kessler, 
2007; Smink, van Hoeken, & Hoek, 2012). The prevalence of AN in the United States 
has been estimated to be .9% for women and .3% for men (Hudson et al., 2007), though 
higher rates have been recorded in an Australian study of female twins, with lifetime 
prevalence of AN estimated at 1.9% (Smink et al., 2012). Since the publication of the 
DSM 5 in 2013, estimates of the lifetime prevalence of AN has increased to up to 1.3% 
of the general population. This could be attributed to the redefinition of the diagnostic 
criteria as presented by the DSM 5, which is less stringent than those of its predecessor. 
For instance, the DSM 5 no longer requires the presence of amenorrhea in women for a 
diagnosis of AN (APA, 2013).  
 AN is the only psychiatric diagnosis that can lead to death by its very nature, 
often as a result of medical complications brought about by extreme weight loss if 
untreated (APA, 2013; Arcelus, Mitchell, Wales, & Nielsen, 2011). Of all mental 
disorders, AN has the highest mortality rate (Steinhausen, 2002) with estimates of 10% 
mortality rate per decade of illness (Sullivan, 2002). Other serious medical consequences 
have been observed in adult individuals presenting significantly low weight, such as liver 
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damage (Gaudiani, Sabel, Mascolo, & Mehler, 2012), bone density loss and osteoporosis 
(Baker, Roberts, & Towell, 2000; Gaudiani et al., 2012), renal failure (Takakura et al., 
2006), cardiac complications (Caseiro & Frishman, 2006), electrolyte imbalances (Turner 
& Shapiro, 1992), constipation, hypothermia, lethargy and, among female patients, 
amenorrhea at times associated with infertility (APA, 2013). Many more physical 
complications might arise, primarily as a consequence of acute or chronic starvation. 
Having a diagnosis of AN has also been associated with a high rate of suicidality and 
death by suicide, especially among men. In 2005, Birmingham, Su, Hlynsky, Goldner, 
and Gao conducted a cross-sectional study of patients referred to an adult tertiary care 
eating disorders program in British Columbia. The researchers reported that, out of 954 
patients, 25 had died. Of these 25, 17 were diagnosed with AN (68%), while seven had 
received a diagnosis of Bulimia Nervosa (BN) and one had received a diagnosis of 
EDNOS. Out of the 17 deceased AN patients, 16 were male (94.1%) and the researchers 
reported the causes of death were suicide (n=7), pneumonia (n=2), hypoglycemia (n=2), 
liver disease (n=2), cancer (n=2), alcohol poisoning (n=1) and subdural hemorrhage 
(n=1). Thus, developing effective treatments for AN is extremely important. 
Treatment Studies on Anorexia Nervosa  
Due to the complex and diverse array of AN symptoms, treatment programs for 
the disorder are typically comprised of teams made up of both medical and psychological 
professionals that target several multidisciplinary factors, including medical stabilisation, 
weight increase to a healthy level, and psychotherapy (Olmsted et al., 2007). Treatment 
can occur in an inpatient setting or through day-treatment, outpatient treatment or through 
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a combination of the three (Fairburn, 2005). However, despite the negative consequences 
of the disorder and risk of death, research has shown that AN demonstrates a resistance to 
treatment (Hay et al., 2012).  In a meta-analysis of 119 studies that included outcome 
statistics for AN treatment programs, Steinhausen (2002) found that, following 
specialized treatment, on average only 46.9% of patients showed full recovery. Similarly, 
Berkman, Lorne, and Bulik (2007) conducted a review that analyzed data from 56 studies 
on eating disorders, including AN, and reported that, at 6-12-year follow-up, as few as 
27-58% of individuals treated for AN showed a good outcome.  
While individuals who complete treatment for AN have the best chance of 
obtaining significant symptom reduction (DeJong, Broadbent, & Schmidt, 2012), 
research also indicates that individuals with AN who have good outcomes at the end of 
treatment are still liable to relapse (Guarda, 2008), and susceptible to developing a 
chronic form of the disorder (Hay et al., 2012). One review article noted that, on average, 
relapse rates after successful weight restoration in AN patients following intensive 
treatment were as high as 30-50% within the first year of discharge (Guarda, 2008). 
Another literature review of treatment programs for AN (Steinhausen, 2002) reported that 
as many as 20.8% of individuals affected by AN who receive treatment develop a chronic 
form of the disorder.  
High rates of attrition have also been observed in treatment settings of AN 
(Guarda, 2008; Kaye et al., 1999; Woodside, Carter, & Blackmore, 2004). Guarda (2008) 
found that as many as 30-50% of patients admitted to specialty programs drop out 
prematurely. In a review article, Watson and Bulik (2013) stated that attrition rates in 
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treatment settings for the disorder are "inordinately high compared with many 
psychological conditions". Similarly, Kahn and Pike (2001) found evidence that in the 
earliest stages a considerable percentage of individuals with AN do not successfully 
complete inpatient treatment. In an analysis of 26 studies of Eating Disorders, Fassino, 
Pierò, Tomba, and Abbate-Daga (2009) found that dropout rates ranged from 20.2-51% 
for inpatient treatment and 29-73% for outpatient treatment. Predictors of dropout in 
individuals with AN have been difficult to establish with only very limited research 
undertaken on the topic and, to date, data has generally been inconclusive or 
contradictory (Fassino et al., 2009; Kahn & Pike, 2001). Some research suggests that the 
AN binge-purge subtype is predictive of premature treatment termination (Bandini et al., 
2006; Elbaky et al., 2014; Fassino et al., 2009; Wallier et al., 2009; Surgenor, Maguire, & 
Beumont, 2004; Woodside et al., 2004) and the requirement of a relatively longer course 
of treatment (van Son, van Hoeken, van Furth, Donker, & Hoek, 2010). Repeated 
hospitalisation for AN may also decrease the likelihood that individuals with AN will 
complete treatment (Kahn & Pike, 2001), and older age at detection as well as a longer 
duration of illness may negatively impact the ability of individuals with AN to achieve a 
full recovery (Berkman et al., 2007; van Son et al., 2010). However, other studies have 
failed to find a correlation between drop-out and severity of AN (Sly, Morgan, 
Mountford, & Lacey, 2013). 
As reviewed above, treatment studies on AN have been characterized by high 
rates of treatment drop-out, low rates of recovery, as well as high rates of relapse pointing 
to the need to identify novel ways of improving treatment outcome. Research conducted 
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thus far has evaluated a variety of treatment approaches including nutritional counseling, 
medication, different types of individual treatment such as cognitive behavior therapy 
(CBT) or interpersonal therapy, as well as multifaceted specialized inpatient and 
outpatient settings. However, only a limited number of randomized control trials (RCTs), 
the gold standard in treatment research, have been undertaken to study and compare the 
effectiveness of different forms of treatment for AN in adults and findings have been 
mixed. In a review of the literature on RCTs designed specifically for AN between 1980 
and 2011, Watson and Bulik (2013) found a total of 48 RCTs that studied different 
treatments. Twenty-nine of these RCTs were pharmacological trials, while only 19 
looked at different psychological treatments. Of these, three studies examined 
maintenance therapies instead of acute treatment, eight focused on family based therapy 
(FBT) for adolescents with AN, four focused on FBT for both adolescents and young 
adults, two looked at other therapies for both adolescents and adults, and only two studies 
focused on the treatment of adults only. Of the 19 studies that focused on psychological 
treatments, only two adolescent studies had 100 participants or more at start of trial. Two 
other review articles have since been published (Hay, 2013; Zipfel Giel, Bulik, Hay, & 
Schmidt, 2015), which identified seven additional RCTs with adults participants. 
However, research on AN treatment remains limited and continues to face a number of 
challenges.  
 The issues associated with AN treatment, namely treatment non-adherence and 
attrition, also have a negative impact on RCTs. Notably, the recruitment and engagement 
of individuals affected by AN in treatment studies has consistently been found to be 
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problematic (Guarda, 2008, Wilson, Grilo, & Vitousek, 2007). For example, in one of the 
earliest RCTs to study AN treatment for adults, Channon, de Silva, Hemsley, and Perkins 
(1989) only succeeded in recruiting a total of 24 participants, reduced to 21 after attrition. 
This has led to significant adverse effects on research; small sample sizes are often 
exacerbated by high attrition rates during treatment (Watson & Bulik, 2013) diminishing 
the results of findings. For example, in another early RCT, Treasure et al. (1995) sought 
to assess the effectiveness of cognitive analytical therapy (CAT) and educational 
behaviour therapy (EBT) for AN. However, the results were uninterpretable due to small 
sample size compounded by high attrition. Likewise, Serfaty, Turkington, Heap, 
Ledsham, and Jolley (1999) failed to successfully assess the effectiveness of cognitive 
therapy (CT) in an outpatient treatment for AN in adults with dietary counselling as a 
control group due to a 100% attrition rate from this latter group by the third month of 
trial. In a review article, Fairburn (2005) suggested that further comparison of different 
forms of AN treatment was barely possible until the issues of sampling and attrition have 
been addressed. In their recent overview of AN treatment, Zipfel et al. (2015) were more 
optimistic and highlighted a few new studies that focused on particular ED subgroups and 
contained larger sample sizes. However, the authors noted that considerable research was 
still needed in the field. 
Certain design limitations and variances also present particular challenges to the 
study of AN treatment and impede the successful comparison of different research 
findings. For example, participation criteria and duration of treatment intervention varies 
from study to study (Wilson et al., 2007) and researchers in the field have yet to agree 
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upon a common definition of successful AN remission and positive outcome (Guarda, 
2008), which can vary from measuring gains in weight, percent of ideal body weight, 
and/or a combination of weight and presentation of eating disorder symptomatology. 
Moreover, studies often employ different instruments to assess treatment outcome, 
including body mass index (BMI) which calculates an individual’s ideal body weight by 
dividing their weight in kilograms by the square of their height in meters (Keys, Fidanza, 
Karvonen, Kimura, & Taylor, 1972); scores in the Eating Disorder Examination (EDE) 
and its self-report questionnaire variant (EDE-Q), which assesses eating disorder 
psychopathology and behaviour over the previous 28 days (Cooper & Fairburn, 1987; 
Fairburn & Cooper, 1993; Fairburn & Beglin, 1994); or the Morgan-Russell Assessment, 
which evaluates the clinical state over the previous 6 months using 5 clinician-rated 
subscales and gives both an average outcome score and a general outcome category, the 
latter based on weight and menstruation, and resulting in three outcome options; good, 
intermediate, and poor (Morgan & Hayward, 1988).  
Additionally, the core rationale of RCTs involves the inclusion of control groups 
or alternative treatment models, however, this approach seems problematic in the AN 
literature. As Watson and Bulik, (2013) highlight, including a control group for proper 
research design poses ethical concerns inherent to assigning severely ill patients to a no-
treatment control group or assigning them to a treatment that might not be of their 
preference. Groups assigned to a no-treatment control protocol may also be affected by 
attrition as they seek treatment elsewhere (Crisp et al, 1991). It is of note that no-
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treatment control groups are absent in randomized controlled studies of psychological 
treatments for this population published since 1991. 
To date, cognitive behavioural therapy (CBT) has been the focus of more studies 
than any other psychological approach in the treatment of adults affected by AN (Wilson, 
et al., 2007). However, as previously discussed regarding RCTs of AN treatment, dropout 
was an issue in the majority of studies to assess CBT over the past two decades, with 
attrition rates ranging from 30% to 65% and full sustained recovery, defined as BMI 
restored to within a normal range and a significant decrease in AN symptomatology, 
varying from 30% to as little as 8% of participants (Ball & Mitchell, 2004; Byrne, 
Fursland, Allen, & Watson, 2011; McIntosh et al., 2005; Zipfel et al., 2014). While one 
RCT on CBT reported a higher rate of retention at 87% (Touyz et al., 2013), only 17.4% 
of all the participants from this study attained full recovery by 12-month follow-up. 
Overall, findings from RCTs on CBT do not suggest that it is significantly superior to 
other treatment approaches. For example, McIntosh et al. (2005) measured the 
effectiveness of CBT therapy compared to interpersonal therapy with a nonspecific 
approach as an active control condition in 56 adolescent and adult patients with AN. 
However, contrary to the authors’ main hypothesis, participants who completed the 
nonspecific treatment group showed the most significant improvement in 
symptomatology, with the interpersonal therapy group showing the least improvement.   
Studies that have assessed treatment approaches other than CBT for adults with 
AN have also generally reported poor outcomes and high rates of attrition. For example, 
Dare, Eisler, Russell, Treasure, and Dodge (2001) recruited 82 adult participants with AN 
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symptoms to compare three different therapy approaches (outpatient Family Therapy, 
Focal Psychodynamic Psychotherapy, Cognitive-Analytic Therapy, and a Treatment-As-
Usual (TAU) control group), but reported that only 65.8% of individuals (54 participants) 
completed treatment. Further, only 32% of 21 individuals across all three psychotherapies 
(8 in Family Therapy, 7 in Focal Psychodynamic Psychotherapy, and 6 in Cognitive-
Analytic Therapy) no longer met criteria for AN at one-year follow-up, while this was the 
case for only 5% of the TAU group (one participant). Two recent studies have attempted 
to compare the efficacy of the Maudsley Model of Anorexia Nervosa Treatment for 
Adults (MANTRA) and that of a specialist supportive clinical management treatment 
(SSCM; Schmidt et al., 2012; Schmidt et al., 2015). High rates of attrition were reported 
in the 2012 RCT (26% of the MANTRA group and 37% of the SSCM group) while the 
2015 RCT reported better retention. However, both studies reported that neither therapy 
approach provided significantly superior results and full symptomatic recovery was only 
achieved in a minority of participants.  
While Family Based Therapy (FBT) is the leading evidence based approach for 
the treatment of AN in adolescents (le Grange & Lock, 2005; Winston, Paul, & Juanola-
Borrat, 2011; Zipfel et al., 2015), part of the relative success of this method may lie in the 
fact that it requires parents to take control over the adolescent’s problem behaviours 
(Guarda, 2008; Wilson et al., 2007). Lower reported treatment attrition rates and better 
outcome from this population could partially be a result of parents possessing the 
authority to compel their child to attend sessions and complete treatment, which could act 
in part to circumvent the patient's own drive to refuse treatment and override their lack of 
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motivation (Guarda, 2008; Halmi, 2008; Wilson et al., 2007). Statistical data do not 
suggest that FBT is a more effective therapeutic approach than other treatment types for 
adults, individuals with an older age at onset, or longer history of AN (Fairburn, 2005; 
Whitney et al., 2012; Wilson et al., 2007). 
Elsewhere, statistics are inconclusive on whether or not inpatient or outpatient 
treatment is more effective. In a review of the literature investigating the strengths and 
weaknesses of inpatient versus outpatient treatment of AN, Meads, Golds, and Burls 
(2001) concluded that too few studies have been completed on the topic and the limited 
number of studies available suffer from underpowered analyses and bias, making it 
impossible to come to any definitive conclusions on the subject. No RCTs have 
conducted a comparison of inpatient versus outpatient treatment for adults with AN, 
though two RCTs studied the topic in adolescent populations (Crisp et al., 1991; 
Herpertz-Dahlmann et al., 2014). However, neither of these studies found one treatment 
setting to be superior to the other and both studies suffered from relatively high attrition 
rates and, overall, a significant percentage of participants still scored a poor outcome at 
follow-up, regardless of treatment setting.  
Further, pharmacological treatments have not proven to have a clear and 
significant effect on weight gain or on reduction of eating disorder symptomatology in 
individuals with AN. For example, fluoxatine does not appear to decrease symptoms of 
obsessive-compulsiveness nor assist in weight restoration (Watson & Bulik, 2013) and 
antipsychotics have not been found to have an impact on AN symptomatology (Kishi, 
Kafantaris, Sunday, Sheridan, & Correl, 2012; Lebow, Sim, Erwin, & Murad, 2013). This 
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has led the medical field to conclude that antipsychotics should not be used in the 
treatment of AN until more compelling data is available (Zipfel et al., 2015).   
In summary, treatment studies on AN have been characterized by relatively poor 
outcomes, with high rates of treatment refusal, attrition, and relapse. A significant 
proportion of patients with AN end up developing a chronic form of the disorder. Thus, 
there is a clear need to develop more effective therapeutic approaches that will better 
engage individuals with AN in treatment and improve treatment outcomes.  
Motivation to Change in Anorexia Nervosa  
Anorexia nervosa (AN) has a reputation for being “difficult to treat” among 
clinicians and individuals with this disorder are often viewed as lacking motivation to 
change (Vitousek et al., 1998). Further, in the eating-disorder literature, a discrepancy 
between the individual’s readiness for change and the behavioral requirements of various 
treatments have been associated with a higher likelihood noncompliance, attrition, and 
relapse (Geller, Cockell, & Drab, 2001). A key element responsible for the challenges 
faced in engaging and successfully treating individuals with AN may lie in the disorder’s 
largely egosyntonic nature (Guarda, 2008; Tan, Hope, & Stewart, 2003; Vitousek et al., 
1998). Tan et al. (2003) describe this phenomenon as a state in which many individuals 
with AN perceive the disorder to be a core part of their identity. Any steps taken that are 
aimed at increasing weight or reducing weight control behaviors in individuals with AN 
can therefore become viewed as a threat to the self-concept and an attack on their identity 
(Espindola & Blay, 2009, Virousek et al., 1998). In a qualitative study of patients’ 
perceptions of AN, Nordbø, Espeset, Gulliksen, Skårderud, and Holte (2006) reported 
WORKING ALLIANCE, MOTIVATION, AND ANOREXIA NERVOSA 
 
26 
 
that, for many individuals with the disorder, the associated behavioural symptoms are 
seen as psychologically purposeful, detailing that it provides self-confidence, mental 
strength, and a sense of security and structure. Participants in another qualitative study 
articulated the belief that AN provides them with a sense of success when they might feel 
lacking in other areas of their life such as school, work, or social settings (Nordbø et al., 
2012). It has also been theorized that AN can act as a useful strategy for many individuals 
in order to avoid undesirable emotions or the stressors of interpersonal relations (Arkell 
& Robinson, 2008).  
The harmful behaviour of individuals with AN (e.g., food restriction, abuse of 
diuretics, over exercising) are often interpreted by them as positively supporting their 
needs, sense of safety, and goals to be their ideal self, with weight control a positive, 
desirable end (Serpell, Treasure, Teasdale, & Sullivan, 1999), and they can struggle to 
conceive life without the disorder (Espindola & Blay, 2009). For instance, individuals 
with AN tend to deny the presence of problem behaviours, consequences of food 
restriction, and severity of weight loss (Nordbø et al., 2012; Vitousek et al., 1998; 
Vitousek, Daly, & Heiser, 1991). Studies also suggest that relative to other eating 
disorders, individuals with AN may be the least likely to seek out treatment (Abbate-
Daga, Amianto, Delsedime, De-Bacco, & Fassino, 2013) and it is possible that close to 
50% of individuals living with AN go undetected (Keski-Rahkonen et al., 2007). Those 
who pursue treatment are unlikely to do so entirely of their own volition, but rather at the 
request of concerned friends or family members (Vitousek et al., 1998). In addition, the 
egosyntonic features of AN often have negative effects on interactions between 
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healthcare providers and individuals affected by the disorder. For example, clinicians 
have reported that AN patients frequently have difficulties trusting their care providers 
and difficulty being willing to openly share power in these relationships (Warren, 
Crowley, Olivardia, & Schoen, 2009). Individuals with AN often present as socially 
inhibited and guarded, which may also impact their relationships with the therapists 
(Carter, Kelly, & Norwood, 2012). In addition, qualitative research indicates that adult 
AN patients in various settings report a preference for clinical interactions that combine 
collaboration, expert knowledge, patience, acceptance of the client, and challenge to their 
behaviours - a delicate balance that is often difficult for clinicians to achieve and 
maintain (Gulliksen, Espeset, Nordbø, Skårderud, Geller, Holte, 2012). Consequently, 
healthcare workers often report feeling frustrated and burnt out working with this 
population (Golan, Yaroslavski, & Stein, 2009; Warren et al., 2009). 
Ultimately, the egosyntoncity that AN patients often experience can be associated 
with a lack of motivation to engage in therapeutic work, as well as strong ambivalence or 
outright refusal to undertake the necessary steps to create lasting change (Starzomska, 
2009). High levels of ambivalence towards treatment and recovery have been consistently 
reported in individuals with AN (Colton & Pistrang, 2004; Marzola, Abbate-Daga, 
Gramaglia, Amianto, & Fassino, 2015; Reid, Burr, Williams, & Hammersely, 2008; 
Serpell et al., 1999; Williams & Reid, 2010) and have been shown to impact motivation 
for change and treatment outcome, resulting in a consistently poor prognosis (Carter, 
Mercer-Lynn, et al., 2012; Carter & Kelly, 2015; Vitousek et al., 1998).  
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Wade, Frayne, Edwards, Robertson, and Gilchrist (2009) have posited that 
motivation is correlated with symptom changes in individuals with AN. On this premise, 
the authors stated that an important course of study in AN treatment research should 
include the examination of ways in which motivation to change can be enhanced in 
individuals affected by the disorder. Supporting this argument, Geller, Brown, Zaitsoff, 
Goodrich, & Hastings (2003) report that eating-disorder patients are more amenable to 
treatments that take the individual’s readiness for change into account and consider these 
types of treatment to be more effective. Similarly, in a 2008 study, Bewell and Carter 
suggested that readiness to change “is the mechanism by which eating disorder 
symptomatology predicts success in a treatment program.” A recent RCT supports the 
association between patient motivation and outcome in individuals with an ED (Carter & 
Kelly, 2015). In this study, the authors reported that a quicker decrease in global eating 
disorder pathology was correlated to higher baseline levels of autonomous motivation, 
defined as motivation initiated from within the self and theorized to encourage more 
long-lasting change. In addition, the authors did not find an association between 
controlled motivation and outcome, defined as motivation occurring due to external 
forces and theorized to negatively interact with change.  
Given the high level of ambivalence and lack of motivation towards treatment 
reported in individuals with AN and the associated difficulties in engaging and retaining 
patients in the treatment process, it is crucial that researchers identify novel ways to 
enhance motivation for treatment in this population. Further, there is a need to identify 
methods to promote the development of better working relationships with care providers 
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in order to successfully engage patients with AN in the treatment process and improve 
treatment outcomes.  
Working Alliance and Anorexia Nervosa    
The working alliance may be a factor that contributes to the relatively poor 
treatment outcomes and high rates of attrition found in individuals affected by AN. As 
previously discussed, the working alliance has been identified as one of the strongest 
predictors of treatment outcome across a diverse range of disorders (Horvath et al., 2011; 
Martin et al., 2000) and low levels of working alliance have been correlated to treatment 
attrition (Sharf et al., 2010). An extrapolation of the results observed in other diagnoses 
would therefore suggest that a strong working relationship should likewise be associated 
with better treatment outcomes in the AN population. It has also been noted that in the 
treatment of AN, individuals with the disorder and clinicians working in the field often 
place significant importance on the working alliance (Brown, 2015; Graves et al., 2017). 
For example, in a qualitative study of eight patients with AN, Sly, et al. (2014) reported 
that developing a positive working relationship with their care provider was identified as 
key to the treatment process for most participants, and that having a negative working 
relationship was perceived by some to adversely impact their motivation for recovery. 
The authors also suggested that the importance of the working alliance could potentially 
be observed as early as the first session. Thus, having a clear understanding of the 
relationship between working alliance, motivation, treatment compliance, and outcome in 
individuals with AN may potentially lead to the development of clinical strategies that 
target this relationship to maximize treatment outcome.  
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 However, perhaps surprisingly, very little research has been undertaken to study 
the working alliance and its relationship to motivation and treatment outcome in 
individuals with AN to date, and therefore the role of the working alliance in the 
treatment of eating disorders remains poorly understood. In a recent literature review on 
the working alliance and eating disorders, Zaitsoff et al. (2015) found that of the 19 
relevant studies they identified, only eight assessed the working alliance specifically in 
the treatment of individuals with AN. Of these eight studies, five focused on adolescents 
and the remaining three assessed an adult population. The authors stressed the importance 
of conducting additional research on the topic as the role of the working alliance in the 
treatment of eating disorders is not yet clearly defined and researchers have yet to 
identify an effective course of treatment for AN in adults affected by the disorder. 
Likewise, Brown (2015) underlined the limited amount of research so far undertaken on 
the working alliance in the treatment of AN, identifying the subject as a relevant field of 
study especially in the case of adults affected by the disorder, and posited that a 
longitudinal research approach would be most effective for future research. In addition, 
the particular characteristics of individuals with AN that affect the development of a 
working alliance in the AN population have not yet been clearly identified. Thus, 
shedding further light on the relationship between working alliance, motivation to 
change, and treatment outcome in the adult AN population is a necessary research 
endeavour.  
To date, research would suggest a positive correlation between working alliance 
and treatment outcome in AN in early and mid-adolescents. In a recent meta-analysis, 
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Graves et al. (2017) reviewed 20 articles that reported measures of the working alliance 
in eating disorder treatment, nine of which analysed AN populations. The authors 
reported that the working alliance was significantly associated with a more positive 
treatment outcome in younger adolescents and in those treated for AN in contrast to other 
EDs. However, this was not found to be significant in older adolescents and adults with 
an ED. At present, six studies have examined the relationship between working alliance 
and either premature treatment termination or treatment outcome in adults with AN, one 
of which also assessed motivation. In the first, Gallop, Kennedy, and Stern (1994) found 
that patients who completed an inpatient treatment program (N=21) reported a better 
working alliance at week three of treatment than those who terminated treatment 
prematurely (N=10). In addition, they reported that the working alliance continued to 
improve during the course of treatment for those who completed the clinical program. 
While the results of this study must be viewed with caution due to the relatively small 
sample size (N=31), the authors suggested that premature discharge could be linked to a 
poor working alliance.  
In the second study, Sly et al. (2013) examined the roles of the working alliance 
and motivation to change in predicting premature treatment termination in adults with 
AN participating in a specialized hospital inpatient treatment program (N=90). The 
authors found that the working alliance, as measured using the Working Alliance 
Inventory (WAI) during the first seven days of treatment reliably predicted patient 
completion of treatment. In their study, participants who had higher scores on the WAI 
were subsequently more likely to successfully complete treatment compared to those who 
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prematurely terminated treatment. Sly et al. (2013) reported that levels of motivation did 
not differ significantly between treatment completers and non-completers. In addition, no 
correlation was found between measures of motivation taken at admission or at week four 
and treatment outcome. These findings seem to be in contrast to those reported in another 
2013 study that assessed the relationship between motivation and working alliance in 
individuals with AN. Mander, Teufel, Keifenheim, Zipfel, and Giel (2013) found that 
being in the contemplation stage of change was significantly correlated with higher 
ratings of working alliance on all scales later on in treatment whereas being in the pre-
contemplation stage was significantly correlated to lower levels of working alliance. 
However, Sly et al. (2013) suggested that their results may have been affected by the 
chronic nature of their sample and the significantly low levels of motivation reported in 
almost all participants. 
In the third study, Stiles-Shields et al. (2013) assessed the working alliance in two 
different treatment approaches for individuals with “enduring AN”, defined by meeting 
AN criteria for at least seven years (N=63). The authors reported that early working 
alliance, measured during the second week of treatment, was a strong predictor of 
residual ED symptomatology at 12-month follow-up suggesting that a weak initial 
working alliance may predict an increased probability of relapse. It was also found that 
late measures of working alliance taken at the end of treatment significantly predicted 
changes in AN and depressive symptomatology as well as weight gain at end of treatment 
and 12-month follow-up more so than type of treatment. The authors hypothesised that 
their results may have been influenced by the chronic nature of the disorder in their 
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sample, which could have required greater time for benefits of the working alliance on 
outcome to develop. 
In contrast, Brown, Mountford, and Waller (2013a; 2013b) have proposed that, 
while a good working alliance is necessary in the therapeutic process, a re-evaluation of 
assumptions pertaining to the significance of the working alliance in the treatment of AN 
should be reconsidered. The authors caution that therapists might be overestimating the 
influence of the working alliance in AN treatment to the detriment of other, more 
significant contributing factors such as changes in eating habits. Brown and colleagues 
(2013a) conducted a study of 65 adults and adolescents in outpatient CBT treatment of 
AN. The researchers reported that early weight gain predicted subsequent measures of 
working alliance, and that working alliance was not associated with weight gain at time 
of discharge or with the probability of early treatment termination. In fact, the authors 
report that, among treatment completers, higher working alliance scores predicted lower 
weight gain during treatment. In their publication, Brown et al. hypothesize that these 
results, contrasting with others in the literature, may be due to the differences in treatment 
settings and modalities (outpatient vs. inpatient, individual therapist vs. treatment teams). 
In their follow-up study, Brown, Mountford, and Waller (2014) found that in a survey of 
clinicians (N=100) who used CBT in the treatment of individuals with AN, adherence to 
treatment manuals and a focus on weight gain in the early stages of treatment was more 
predictive of a positive outcome than when attention was focused on the development of 
the working alliance. The authors remarked though that the self-report nature of their 
study may have introduced bias and had an impact on the accuracy of reporting by 
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clinicians and suggested that future studies in this area should use more direct data from 
AN patients. 
Most recently, however, Jordan et al. (2017) assessed the working alliance using 
the Vanderbilt Psychotherapy Process Scale (VPPS) in an RCT with 56 AN patients and 
reported findings that suggest low levels of early patient alliance, when measured in 
sessions one through five, might be correlated to premature treatment termination in 
adults with AN. It is important to note, however, that this research used an observer-
based instrument to assess working alliance, while the norm in the AN literature has so 
far been the use of client ratings. 
In summary, the limited research presently available on the relationship between 
working alliance and treatment outcome in adults with AN has produced inconsistent 
results and we do not yet clearly understand what this relationship might resemble or 
entail. Further, no study has yet to examine the potential relationship between working 
alliance, motivation, and treatment outcome. Considering the high rates of ambivalence 
towards treatment, high rates of dropout, and generally pour outcomes reported in adults 
with AN, it is essential that research clarify the relationship between working alliance, 
motivation, and treatment outcome in order to develop better treatment approaches that 
will improve outcomes in adults affected by AN. 
Rationale for the Current Study 
To date, there have been only a handful of studies that have examined the 
working alliance in the treatment of adults who present with AN and its association with 
treatment outcome in this population. Additional research is required to better delineate 
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the relationship between the working alliance, treatment adherence, and treatment 
outcome in AN. The working alliance has, in general, been established as a strong 
predictor of treatment outcome across numerous mental health disorders and 
psychological treatment approaches, with early development of the working alliance 
particularly predictive of outcome (Horvath et al., 2011). However, AN is a disorder that 
is often referred to as treatment-resistant (Hay et al., 2012) with significant rates of 
treatment attrition (Watson & Bulik, 2013) and poor outcomes reported across studies 
(Steinhausen, 2002). In addition, the established features of AN, specifically its ego-
syntonic nature as well as the high degree of ambivalence about recovery present in this 
population, could hinder the development of the working alliance during treatment. This 
has led some researchers to theorize that it may be more beneficial to focus on other 
factors in the treatment of AN, such as early gains in weight and motivation for treatment 
rather than working alliance (Brown et al., 2013b; Carter & Kelly, 2015).  
However, research that has considered the role of the working alliance in the 
treatment of adolescents affected by AN has generally found a positive correlation 
between early working alliance and outcome (Graves et al., 2017) while investigations 
into working alliance and EDs in an adult population have produced contradictory 
findings (Zaitsoff et al., 2015; Brown, 2015). Some studies of adults with AN suggest 
that early gains in weight, not working alliance, are a stronger predictor of outcome, and 
that treatment should prioritize increasing food intake and weight at start of treatment 
rather than focusing on enhancing the working alliance (Brown et al., 2014). Other 
studies propose that early weight gain is not predictive of outcome after the fourth week 
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of treatment and that working alliance is a stronger predictor of outcome when measured 
during the first week of treatment (Sly et al., 2013). However, it is not clear whether 
methodological differences in studies, notably the time at which measures of the working 
alliance were taken and the perspective from which the working alliance was measured 
(client, therapist, or observer), might account for the discrepant findings between studies. 
In addition, while the low levels of motivation reported in individuals with AN have been 
consistently shown to predict a poorer treatment outcome (Carter, Mercer-Lynn, et al., 
2012; Carter & Kelly, 2015; Vitousek et al., 1998), the relationship between motivation 
to change and working alliance in this population is poorly understood and, to date, no 
study has investigated this association. Thus, the present study seeks to add to the 
literature by examining the relationship between working alliance, motivation to change, 
and treatment outcome in adults with AN receiving treatment in a specialized 
inpatient/day-patient program. 
Study Aims 
The main purpose of the present study was to examine the association between 
working alliance, motivation to change, and treatment outcome in the treatment of AN 
through a secondary analysis of data collected in an inpatient/day-patient treatment 
program at the Toronto General Hospital between 2010 and 2014. In addition, the current 
study aims to better understand the factors that influence motivation to change by 
exploring its association with baseline measures of illness severity, AN subtype (i.e., 
binge/purge versus restricting types), and age.  
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 Hypothesis 1: It was hypothesized that changes in levels of autonomous 
motivation for treatment, measured using the Autonomous subscale of the Autonomous 
and Controlled Motivation for Treatment Questionnaire (ACMTQ), would predict levels 
of working alliance between patients and treatment team, measured as WAI Total scores, 
at week four. Specifically, it was expected that increases in autonomous motivation for 
treatment at baseline would be positively associated with working alliance at week four. 
In contrast, changes in controlled motivation for treatment, measured using the 
Controlled subscale of the Autonomous and Controlled Motivation for Treatment 
Questionnaire (ACMTQ) would not act as predictors of working alliance at week four. 
Hypothesis 2: The second hypothesis was that levels of baseline autonomous 
motivation for treatment, as measured by the Autonomous subscale of the ACMTQ, 
would predict outcome (i.e., increases in BMI, and decreases in scores on the EDE-Q 
from baseline to discharge from the treatment program). Baseline controlled motivation 
for treatment, as measures by the Controlled subscale of the ACMTQ, would not show 
this association. 
  Hypothesis 3: It was hypothesized that levels of working alliance between the 
patients and the treatment team, measured by the Working Alliance Inventory (WAI) 
during the fourth week of treatment, would positively predict treatment outcome (i.e., 
treatment completion; increases in BMI, and decreases in scores on the Eating Disorder 
Examination Questionnaire (EDE-Q), a measure of eating disorder symptoms, from 
baseline to discharge from the treatment program). In particular, it was expected that 
higher working alliance would be: a) positively associated with larger BMI increases 
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during the treatment period; and b) positively associated with greater reductions in eating 
disorder symptoms during the treatment period. In addition, it was hypothesized that 
higher working alliance (WAI) scores would predict treatment completion, defined as 
discharge that occurs after 16 weeks of treatment and with BMI and EDE-Q Global 
scores at non-clinical levels, while lower Total WAI scores would predict early treatment 
termination.           
 Finally, the current study also aimed to explore the associations between working 
alliance, early weight change in the first four weeks of treatment, and treatment outcome. 
However, given the conflicting nature of the research findings in this latter area, no 
definite hypotheses were made in this regard. 
Method 
Research Design  
The current study made use of secondary data originally collected for program 
evaluation purposes at the Inpatient/Day Treatment Eating Disorders Program at the 
Toronto General Hospital between 2010 and 2014. The UHN Research Ethics Board 
approved this study. 
Patients 
 Between 2010 and 2014, 108 patients agreed to take part in the research study, 
gave informed consent, and completed a baseline assessment. All patients had a BMI ≤ 
17.5 at baseline and met the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision (DSM-IV-TR) criteria for Anorexia Nervosa (AN) when 
admitted to the program. This diagnosis was made by a psychiatrist or clinical 
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psychologist. See Tables 1 through 3 for demographic and clinical characteristics of the 
sample.  
Out of the original 108 patients, 55 patients dropped out before the fourth week of 
treatment and were therefore unable to complete the Working Alliance Inventory (WAI), 
which was administered in week four. The remaining 53 patients were included in the 
present study. For a summary of changes in sample size, see Figure 1. 
All 53 patients were females diagnosed with AN with a mean age of 30 years 
(range=18 to 63 years). They spent an average of 15.7 weeks in the treatment program, 
with a range of 5 to 25 weeks. The average baseline BMI was 15 kg/m
2
, with a range of 
11-17.4 kg/m
2
, and the average BMI at discharge was 19.6 kg/m
2
, with a range of 15-22.9 
kg/m
2
. Overall, 40 out of the 53 patients (75.5%) completed the sixteen-week treatment 
program at TGH; representing a rate of treatment completion that is higher than 
commonly found in the AN literature. However, when accounting for the initial 108 
patients, the majority of which withdrew before measures of working alliance were taken 
at week four, the treatment completion rate drops to 37%. Regarding AN subtypes, 29 
patients received a diagnosis of AN Bingeing and Purging subtype (AN-BP), with the 
remaining 24 patients receiving a diagnosis of AN, Restricting subtype (AN-R). 
Regarding relationship status, 12 patients (22.7%) reported being in a stable relationship 
at intake (10 married, 2 common-law), while the remaining 77.3% reported being single 
(37 patients), separated (2 patients), or divorced (1 participant). In terms of living 
situation, 24 patients (45.3%) reported living with their parents, 12 patients (22.6%) 
reported living with their spouse and/or children, 11 patients (20.8%) reported living 
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alone, 5 patients (9.4%) reported living with roommates or other family, while living 
situation data was missing for one participant (1.9%). Regarding employment, 25 patients 
(47.2%) reported being unemployed or students, with 26 patients (49.1%) reporting 
various forms of employment and 2 responding “Not Applicable”. In relation to ethnicity, 
48 patients (90.5%) indicated a European/white cultural background, while 3 patients 
indicated other ethnicities (East Indian, West Indian, and Oriental) and 2 other patients 
had missing ethnical background data.  
Treatment 
 The Toronto General Hospital program is a specialized hospital-based, intensive 
treatment program for serious eating disorder cases with voluntary admission. The 
program takes referrals from family doctors and all prospective patients are assessed by a 
psychologist or psychiatrist before baseline. To be admitted into this program, 
prospective patients are required to demonstrate an understanding of the need to 
participate in treatment and acceptance of the program's norms (e.g., staff-supported 
meals). The program is operated by an interdisciplinary team of psychiatrists, 
psychologists, nurses, dietitians, social workers, and occupational therapists. The 
program has space for up to 12 concurrent patients who participate in specialized 
programming for 30-40 hours per week. The main goals include medical stabilization, 
weight restoration (as needed), nutritional rehabilitation with staff-supported meals, and 
the elimination of disordered behaviours such as binge eating, purging, and 
disproportionate physical exercise. The main treatment orientation is cognitive-
behavioural, although patients participate in several groups addressing interpersonal 
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relationships, sexuality, expressive arts, anxiety management, and dialectical behaviour 
therapy. When patients reach a BMI of approximately 18.5 and are medically stable, they 
are transferred to day patient status and continue to attend the program Monday to Friday 
9-5. Patients are discharged from the program, and begin follow-up care, when they reach 
a BMI of 20, with a combined average stay of 16 weeks in the inpatient and day hospital 
components.   
Procedure  
During a pre-admission orientation session, a member of the clinical team asked 
patients if they wished to be contacted by the research team. If so, patients in the current 
study were assessed using the diagnostic items of the Eating Disorder Examination 
(EDE) interview (APA, 2000; Fairburn & Cooper, 1993) and met the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) 
criteria for Anorexia Nervosa (AN) when admitted to the program. The diagnostic items 
of the EDE interview (Fairburn & Cooper, 1993) were administered by a trained 
interviewer. On commencing the treatment program, patients completed the Eating 
Disorder Examination Questionnaire (EDE-Q) and the Brief Symptom Inventory (BSI). 
Objective weight and height were measured at baseline, at week four, and at discharge. 
Delivery of the treatment program was conducted as usual. The Working Alliance 
Inventory (WAI) was administered after four weeks of treatment. At time of discharge, 
the EDE-Q was re-administered. 
Measures  
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 Eating Disorder Examination Questionnaire (EDE-Q; Fairburn & Beglin, 
1994). The Eating Disorder Examination Questionnaire (EDE-Q) is based on the EDE 
interview (Fairburn, & Beglin, 1993), which is considered to be the gold standard eating 
disorder assessment measure. Similar to the EDE, the EDE-Q assess eating disorder 
psychopathology, including key behavioural problems, severity of eating pathology, and 
associated disturbances over the prior 28 days. The EDE-Q is comprised of 36 items and 
four subscales; Shape Concern, Weight Concern, Eating Concern, and Dietary Restraint. 
Items found in the Shape Concern subscale include: “Have you had a definite desire to 
have a totally flat stomach?” and “How dissatisfied have you been with your shape?’; the 
Eating Concern subscale includes: “Have you had a definite fear of losing control over 
eating?”; the Weight Concern subscale contains items such as: “Have you had a definite 
fear that you might gain weight?” and “Have you had a strong desire to lose weight?”; 
and the Dietary Restraint subscale includes: “Have you had a definite desire to have an 
empty stomach with the aim of influencing your shape or weight?” Frequency of 
disordered behaviors is measured by number of days on which symptoms occur and the 
number of individual episodes. The four subscales load into a Global score ranging from 
0 (low) to 6 (high), which is the average of the four subscales, with a clinical cut-off 
point of 4. Higher scores reflect greater pathology. The test-retest reliability and validity 
of the EDE-Q have been well-established; internal consistency of the four subscales have 
been found to yield Cronbach alpha values ranging from .81 to .92 and their test-retest 
reliability has been found to yield Person r values ranging from .81 to .94 (Luce & 
Crowther, 1999).  Internal consistency was high for the sample in the present study, 
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yielding Cronbach’s Alpha values ranging from .83 to .90 for each of the EDE-Q 
subscales at time of admission.  
Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983). The Brief 
Symptom Inventory (BSI) is a shortened form of the revised version of the Symptom 
Checklist-90 (SCL-90-R) and is a self-report symptom scale that assess levels of 
psychological distress in several domains over the previous week. Fifty-three items are 
rated on a 5-point likert scale to reflect different levels of distress from 0 (not at all 
distressed) to 4 (extremely distressed). The BSI produces nine primary psychological 
symptom dimensions: Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, 
Depression, Anxiety, Hostility, Phobia Anxiety, Paranoid Ideation, and Psychosis. 
Additionally, a global score can be calculated from the raw scores of the 53 items - the 
Global Severity Index (GSI), a weighted frequency score obtained from the sum of the 
rates the individual assigns each item. The nine subscales of BSI have demonstrated good 
internal consistency with Cronbach’s coefficient alpha ranging from .71 (psychoticism) 
to .85 (depression; Derogatis & Melisaratos, 1983). Strong test-retest reliability has been 
established with a range of .68 to .91 (Derogatis & Melisaratos, 1983). In the present 
study, internal consistency for the sample was high, yielding Cronbach’s Alphas ranging 
from .70 to .89 at intake. 
Working Alliance Inventory, client version (WAI; Horvath & Greenberg, 
1989). The Working Alliance Inventory, client version (WAI) was designed to measure 
the quality of the working alliance between therapist and client as conceptualized by 
Bordin's (1979) tripartite model including agreement on Goals and Tasks, and the 
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strength of the therapeutic Bond. The WAI is a self-report questionnaire measure and 
consists of 12 statements regarding the client's perception of the therapeutic relationship 
(e.g., "[the therapist] and I understand each other", "[the therapist] perceived accurately 
what my goals were"). The 12 items are divided equally between three subscales: Goals, 
Tasks, and Bond. Answers are rated on a 5-point Likert scale from 1 (never) to 5 
(always). The space in the sentence where the name of the therapist would appear is 
intentionally left blank for the client to complete with their own therapist's name. In the 
data collected for the present research project, this space was completed with "The 
treatment team". Each WAI subscale is scored individually and scores can range from 4 
to 20. Scores are summed to attain a total score ranging from 12 to 60. Higher scores 
indicate a more positive rating of the working alliance. The WAI-C has been found to 
have strong internal consistency with a Cronbach’s alpha coefficient of .93 (Tichenor & 
Hill, 1989), and an inter-rater reliability ranging between .85 and .88 for all subscales 
(Horvath & Greenberg, 1989). Internal consistency was high for the sample in the present 
study, yielding Cronbach’s Alphas ranging from .84 to .85 at week four. 
Autonomous and Controlled Motivation for Treatment Questionnaire 
(ACMTQ; Zuroff et al., 2007). The Autonomous and Controlled Motivation for 
Treatment Questionnaire (ACMTQ) is a self-report questionnaire adapted from the 
Treatment Self-Regulation Questionnaire (TSRQ; Williams, Freedman, & Deci, 1998). 
For the present study, the word “depression” was replaced with “eating disorder”. The 
questionnaire is comprised of two six-item subscales: autonomous motivation for 
treatment (AMTQ) and controlled motivation for treatment (CMTQ). The AMTQ 
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subscale measures motivation initiated from within the self, while the CMTQ subscale 
measures motivation occurring due to external forces and pressures. Items are rated from 
1 (strongly disagree) to 7 (strongly agree) and address a variety of reasons why patients 
may choose to seek treatment. Sample items for the AMTQ subscale include: “Managing 
my eating disorder allows me to participate in other important aspects of my life” and “I 
have carefully thought about treatment for my eating disorder and I believe it is the most 
important thing I can do to get better”, while items for the CMTQ subscale include: “I 
would be ashamed of myself if I didn’t” and “Other people would be upset with me if I 
didn’t”. Strong internal consistency has been reported with a Crobach’s alpha coefficient 
of .83 for the AMTQ subscale and .77 for the CMTQ subscale (Carter & Kelly, 2015). 
Internal consistency was high for the sample in the present study, yielding Cronbach’s 
coefficient alphas of .86 for AMTQ and .74 for CMTQ at baseline.  
Data Analysis 
 IBM SPSS software was used for all data analyses and significance was 
determined at α = .05. The database was first inspected for missing or incorrect data 
using visual scanning and preliminary descriptive reports. Independent samples t-tests 
were conducted to examine baseline differences between the sample used for further 
analyses in the current study and patients whose data were excluded due to attrition 
before week 4 when measures of working alliance were administered. The two groups 
were compared in demographic and clinical variables including age, and duration of 
illness, as well as baseline variables including BMI and scores in the BSI, EDEQ, and 
ACMTQ. To compare the two groups in their proportions of AN subtypes, a Chi-Square 
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analysis of independence was conducted. Next, descriptive statistics were calculated for 
the variables measured at each time point (baseline, 4 weeks and post-treatment). Paired 
sample t-tests were used to examine differences in these mean score changes over time 
and Pearson correlations between all the main study variables. Independent samples t-
tests were used to examine differences between AN subtypes in relevant variables 
including baseline BMI and scores in the BSI, EDEQ, and ACMTQ; BMI and WAI 
scores at week four; discharge BMI; and changes in BMI from baseline to week four, and 
from baseline to discharge. Post hoc power analyses were conducted to evaluate the 
probabilities of capturing various effect sizes with the given sample. 
 To examine Hypothesis 1, hierarchical multiple regressions were conducted to 
determine whether changes in AMTQ and CMTQ scores from baseline to week four 
would act as significant predictors of working alliance measured at week four, after 
controlling for the effects of early weight change. Week four Total WAI score was 
entered as the criterion, with early weight gain entered as a covariate in step 1, and the 
difference between AMTQ and CMTQ scores from baseline to week four as the 
predictors (in two separate models) were entered in step 2. Early changes in motivation 
were selected as the predictor variable since previous research has shown that changes in 
motivation during the first four weeks of treatment were a better predictor of outcome 
than baseline levels of motivation (Carter et al., 2012). Early weight change was selected 
as co-variate to control for the psychological effects of weight gain. Due to missing 
values at different time points in total among these variables, the number of cases 
available for these regression analyses was 51. 
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Next, to examine Hypothesis 2, hierarchical multiple regressions were conducted 
to determine whether baseline AMTQ and CMTQ scores would predict changes in BMI 
and EDE-Q Global scores from baseline to discharge. To control for the possible effects 
of AN subtype, this variable was entered as a covariate on step one; this variable was 
selected as a covariate in all regression analyses with outcome markers as criteria because 
AN subtypes have been shown to have differential outcomes in the literature. Of note, 
EDE-Q Global scores at discharge were only obtained for 36 patients; therefore, this 
analysis and subsequent regression analyses that included this variable were conducted 
using only these 36 entries. Similar post hoc analyses were also conducted with baseline-
to-week-four changes in AMTQ and CMTQ scores as predictor variables. 
Then, to examine Hypothesis 3, hierarchical multiple regressions were conducted 
to determine whether Total WAI scores at week four would act as significant predictors 
of behavioural and symptomatic change during treatment, calculated as change in BMI 
and EDE-Q Global scores from baseline to discharge. To control for the possible effects 
of AN subtype, this variable was entered as a covariate in step one. The predictor was 
entered in step two, with pre-to-post treatment change in BMI and EDE-Q Global scores 
entered as the criteria. Discharge EDE-Q Global scores were available for 36 patients. A 
univariate logistic regression was conducted to determine whether working alliance 
measured at week four would act as a predictor of treatment completion. AN subtype was 
entered as a covariate on step one and week four WAI Total score was entered as a 
predictor on step two, using treatment completion as the criterion. 
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In addition, hierarchical multiple regressions were also conducted to determine 
whether the change in baseline-to-week-four BMI would act as a significant predictor of 
behavioural and symptomatic change during treatment, calculated as change scores in 
BMI and Global EDE-Q from baseline to discharge. To control for the possible effects of 
AN subtype, this variable was entered as a covariate on step one. The predictor variable 
was entered in step two, with pre-to-post treatment change in BMI and EDE-Q Global 
scores entered as the criteria. Discharge EDE-Q Global scores were available for 36 
patients. A univariate logistic regression was conducted to determine whether early 
weight change would act as a predictor of treatment completion. AN subtype was entered 
as a covariate on step one and weight change from baseline to week four was entered as a 
predictor on step two, using treatment completion as the criterion. 
Additional analyses were conducted to examine potential baseline predictors of 
the variables of interest. Separate hierarchical multiple regression analyses were 
conducted to identify significant baseline predictors of AMTQ and CMTQ scores at week 
four. The baseline measure of each criterion variable was entered in step 1 to control for 
their effects. In both cases, early weight gain (baseline to week four) was also entered as 
a covariate to control for the possible psychological effects of weight change. The 
variables examined as potential predictors were entered in step two; these included 
baseline BMI, AN subtype, duration of illness (in years), age, baseline EDE-Q Global 
scores, and baseline BSI Total scores.  
  A hierarchical multiple regression analysis was also conducted to identify 
significant baseline predictors of Total WAI scores at week four. Early weight gain 
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(baseline to week four) was entered as a covariate in step 1 to control for its 
psychological effects. The variables considered as potential predictors were entered in 
step two; these included baseline BMI, AN subtype, duration of illness (in years), age, 
baseline EDE-Q Global scores, and baseline BSI Total scores. 
Results 
Baseline Descriptives and Clinical Characteristics 
At baseline, the sample had an average BMI below the minimum required for AN 
diagnosis (M = 15, SD = 1.3), an increased average BMI at week four (M = 16, SD = 1.4), 
and an average BMI above the clinical cut-off of 18.5 at discharge (M = 19.7, SD = 1.6). 
A paired-sample t-test indicated that, on average, the sample experienced an 
improvement throughout the treatment, showing a statistically significant increase in 
BMI from baseline to week four, t(52)=-8.394, p<.001, representing a moderate-to-large 
effect size and from baseline to discharge, t(52)=-20.052, p<.001, representing a large 
effect size. At baseline, the sample presented an average EDE-Q Global score above the 
clinical cut-off (M = 4.4, SD = 1.5), which decreased below the cut-off by discharge 
among the 36 (67.9%) patients whose EDE-Q data was collected at the end of treatment 
(M = 2.9, SD = 1.5). A paired-samples t-test revealed that this change in EDE-Q Global 
scores was statistically significant, t(35)=7.052, p<.001, representing a large effect size. 
At baseline, the sample presented a moderate mean BSI Global score (M = 2.2, SD = .8) 
indicating that, on average, the patients started their treatment experiencing moderate 
levels of psychological distress. Regarding working alliance, at week four, the sample 
reported moderate mean WAI total scores (M = 38.7, SD = 10.2), indicating that patients 
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reported experiencing only moderate levels of working alliance with the treatment team. 
At baseline, the sample reported relatively high mean autonomous motivation scores on 
the ACMTQ (M = 36.7, SD = 6.1), with no significant change at week four (M = 36.3, SD 
= 5.7) among the 53 patients who remained in the program for at least 4 weeks, and a 
moderate mean score on the controlled motivation for change scale of the ACMTQ (M = 
31.3, SD = 7.2), with no significant change at week four (M = 31.9, SD = 6.6). This 
indicates that the sample reported high levels of controlled motivation on average during 
the first 4 weeks of treatment. More importantly, it indicates that the sample reported an 
unexpectedly high level of autonomous motivation for this population during the same 
period. For a summary of these results, see Table 4.  
Independent samples t-tests revealed no significant differences between the 
analyzed group (N=53) and the individuals whose data were not included in the analysis 
due to attrition (N=55) in baseline and demographic variables. Furthermore, the effect 
sizes for these differences were small. For a summary of these results, see Table 5. 
Similarly, a Chi-Square analysis of independence found no association between early 
attrition and AN subtype (X
2
(2)=1.595, p=.45). 
Correlations Between Study Variables 
Pearson correlations between the study variables revealed several statistically 
significant correlations. BMI at week four was positively correlated with AMTQ scores 
at baseline (r=.290, p<.05) and with the change in AMTQ scores from baseline to week 
four (r=.289, p<.05), suggesting that patients who reported higher autonomous 
motivation for treatment at baseline and patients who reported larger gains in autonomous 
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motivation during the first four weeks of treatment had a higher BMI at week four. 
Change in BMI from baseline to week four was positively correlated with AMTQ scores 
at baseline (r=.316, p<.05) and at week four (r=.300, p<.05) suggesting that individuals 
who reported higher autonomous motivation at start of treatment and those who reported 
higher autonomous motivation at week four showed a higher BMI increase in the first 
four weeks of treatment. Total WAI scores at week four were positively correlated with 
AMTQ scores at baseline (r=.373, p<.01), AMTQ scores at week four (r=.715, p<.001), 
and with the change in AMTQ scores from baseline to week four (r=-.407, p<.001) 
suggesting that those who reported higher autonomous motivation at start of treatment 
and at week four, as well as those who reported a larger increase in autonomous 
motivation during the first four weeks of treatment, reported a higher degree of working 
alliance at week four. Total WAI scores at week four were negatively correlated with BSI 
Global scores at baseline (r=-.377, p<.01), EDE-Q Global scores at baseline (r=-.397, 
p<.01), and EDE-Q Global scores at discharge (r=-.485, p<.01) suggesting that patients 
who presented as more highly distressed and those who reported more severe eating 
disorder symptomatology at discharge, reported lower levels of working alliance with the 
treatment team at week four. BSI Global scores at baseline were positively correlated 
with EDE-Q Global scores at baseline (r=.828, p<.001) and at discharge (r=.764, p<.001) 
suggesting that patients who were more highly distressed at the start of treatment also 
reported more severe eating disorder symptomatology both at baseline and at discharge. 
Finally, age was negatively correlated with discharge EDE-Q Global scores (r=-.472 
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p<.01) suggesting that younger patients presented more severe eating disorder 
symptomatology at discharge.  
Pearson correlations between AMTQ and CMTQ at baseline and at week four 
were calculated. This analysis revealed that the two variables were not correlated at either 
time, providing evidence that these scores represent measures of two different constructs.  
Did Motivation for Treatment Predict Working Alliance? 
The first goal of the current study was to examine the association between 
motivation for treatment and working alliance. Hypothesis 1 stated that changes in levels 
of autonomous motivation for treatment from baseline to week four, measured by the 
Autonomous subscale of the ACMTQ would predict level of working alliance at week 
four, as measured by the WAI, but that early changes in controlled motivation would not. 
This hypothesis was investigated using two multiple regression analyses with WAI Total 
scores at week four as the dependent variable, either changes in AMTQ or CMTQ scores 
from baseline to week four as the predictor variables, and changes in BMI from baseline 
to week four entered as the covariate in the first step. Results of these analyses indicated 
that, after controlling for the effects of early weight gain, baseline-to-week-four increases 
in AMTQ scores were a significant predictor of Total WAI scores at week four, b = -
.820, t = -3.101, p<.01. The prediction model was significant (F(2,48)=7.32, p<.01) with 
an R
2
 of .234, meaning that 23.4% of the variability in working alliance at week four was 
explained by changes in autonomous motivation from baseline to week four. This means 
that greater changes in autonomous motivation for treatment was associated with a better 
working alliance during the fourth week of treatment. In contrast, baseline-to-week-four 
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changes in CMTQ did not represent significant predictor of Total WAI scores in week 
four, b = -.38, t = -1.472. Details of these results can be found in Table 6. 
Did Baseline Motivation for Treatment Predict Treatment Outcome? 
Due to the high levels of ambivalence toward treatment and recovery consistently 
reported in individuals with AN (Colton & Pistrang, 2004; Marzola et al., 2015; Reid et 
al., 2008; Serpell et al., 1999; Williams & Reid, 2010), the present study sought to 
examine whether autonomous or controlled motivation to change were associated with 
treatment outcome. Hypothesis 2 stated that baseline levels of autonomous motivation for 
treatment would be associated with a better treatment outcome whereas controlled 
motivation would not. This hypothesis was investigated using two multiple regression 
analyses with changes in BMI and EDE-Q Global scores from baseline to discharge as 
the dependent variables. The results of these analyses indicated that, after controlling for 
the effect of AN Subtype, baseline AMTQ scores were not a significant predictor of 
change in BMI from baseline to discharge, nor of change in EDE-Q Global scores from 
baseline to discharge. In addition, baseline CMTQ scores were not a significant predictor 
of change in BMI from baseline to discharge, nor of change in EDE-Q Global scores 
from baseline to discharge. Further, post hoc analyses indicated that baseline-to-week-
four changes in AMTQ were not a significant predictor of change in BMI from baseline 
to discharge, nor of change in EDE-Q Global scores from baseline to discharge. Finally, 
baseline-to-week-four changes in CMTQ scores were not a significant predictor of 
change in BMI from baseline to discharge, nor of change in EDE-Q Global scores from 
baseline to discharge. This suggests that neither autonomous or controlled motivation for 
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treatment at baseline, nor changes in these variables over the first four weeks of 
treatment, were predictive of changes in weight or symptomatology from admission to 
discharge, once AN subtype was accounted for. Details of these results are presented in 
Tables 7 and 8. 
Did Working Alliance Predict Treatment Outcome? 
Hypothesis 3 stated that the level of working alliance between the patients and the 
treatment team, measured by the Working Alliance Inventory (WAI) during the fourth 
week of treatment, would positively predict treatment completion and outcome in patients 
attending treatment for AN. This was investigated using two multiple regression analyses 
with changes in BMI and EDE-Q Global scores from baseline to discharge as the 
dependent variables, Total WAI scores at week four as the predictor variables, and AN 
subtype entered as a covariate in the first step. The results of these analyses indicated 
that, after controlling for the effect of AN Subtype, week four Total WAI scores were not 
a significant predictor of change in BMI from baseline to discharge, nor of change in 
EDE-Q Global scores from baseline to discharge. In addition, hierarchical logistic 
regressions, after controlling for the effect of AN subtype, did not find Total WAI scores 
at week four to be a significant predictor of treatment completion. Details of these results 
are presented in Tables 7 through 9. Thus, contrary to expectations, this suggests that 
working alliance at week four was not a significant predictor of treatment completion nor 
outcome in the current study. 
Post Hoc Power Analysis 
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 Post hoc power analyses were conducted for the regressions. The power for a 
sample of N=53 to capture a moderate effect size was 70%, below the recommended 
power level of 80%. Similarly, the power to capture a moderate effect size in a sample of 
N=36, as is the case of the regression analyses that include discharge EDE-Q measures, 
was of 50%. These results confirm that the regression analyses were underpowered 
(Cohen, Cohen, West, & Aiken, 2003). 
Exploratory Analyses  
Given the conflicting results reported in studies thus far on the importance of 
working alliance versus early weight gain in predicting treatment outcome in the AN 
population (Brown et al., 2014; Sly et al., 2013), this study examined the relationship 
between early weight gain and treatment outcome. A multiple regression analysis, 
controlling for the effect of AN Subtype, did not find the change in baseline-to-week-four 
BMI to be a significant predictor of change in BMI from baseline to discharge, nor of 
change in EDE-Q Global scores from baseline to discharge. Furthermore, using binary 
logistic regression, after controlling for AN subtype, early weight gain was not found to 
be a significant predictor of treatment completion. These findings suggest that the amount 
of weight gain during the first four weeks did not predict overall weight gain from 
admission to discharge, symptomatic change from admission to discharge, or early 
treatment termination. Details of these results are presented in Tables 7 through 9. 
Hierarchical multiple regressions were conducted to identify baseline predictors 
of WAI, AMTQ, and CMTQ scores at week four, after entering weight gain (baseline to 
week four) as a covariate. The predictor variables included baseline BMI, AN subtype, 
WORKING ALLIANCE, MOTIVATION, AND ANOREXIA NERVOSA 
 
56 
 
duration of illness (in years), current age, baseline EDE-Q Global scores, and baseline 
BSI Total scores. The results of these analyses indicated that none of the baseline 
variables were significant predictors of AMTQ, CMTQ, or Total WAI scores at week 
four. Details of these results can be found on Tables 10, 11, and 12. This suggests that 
baseline severity of illness, level of distress, and age did not seem to have an impact on 
subsequent reports of motivation for treatment (autonomous or controlled) or working 
alliance with the treatment team.  
Independent sample t-tests revealed that, at baseline, patients diagnosed with AN 
restricting subtype (AN-R) reported lower BSI scores (M = 1.7, SD = .8) than patients 
diagnosed with AN binging/purging subtype (M = 2.6, SD = .6), this difference between 
groups was statistically significant, t(50)=-4.261,p<.001, representing a large effect size. 
In addition, AN-R patients also reported lower mean EDE-Q Global scores (M = 3.7, SD 
= 1.7) than AN-BP patients (M = 4.95, SD = 1.0) at baseline, t(51)=-3.380,p=.001, 
representing a large effect size. The mean score for the AN-R group was below the 
clinical cut-off of 4 whereas the mean score for the AN-BP group was above the clinical 
cut-off. Regarding BMI, AN-R patients had a lower mean BMI at week four (M = 15.5, 
SD = 1.4) than AN-BP patients (M = 16.4, SD = 1.3), t(51)= -2.471,p<.05, representing a 
moderate-to-large effect size. AN-R patients presented a greater mean change in BMI 
from baseline to discharge (M = 5.2, SD = 1.6) than AN-BP patients (M = 4.2, SD = 1.7), 
t(51)=2.168, p<.05, representing a moderate effect size. AN-R patients also reported a 
higher mean Total WAI score at week four (M = 42.7, SD = 9.3) than AN-BP patients (M 
= 35.5, SD = 9.8), this difference between groups was statistically significant, t(51)=-
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2.711, p<.01, representing a moderate-to-high effect size. The groups did not differ 
significantly in their AMTQ or CMTQ scores at baseline or week four. 
In summary, these findings indicate that AN-R patients, compared to AN-BP 
patients, reported less severe eating disorder symptomatology and distress at baseline. 
The AN-R group also presented with a lower mean BMI at time of admission, but this 
difference was not statistically significant. In addition, they reported a better working 
relationship with the treatment team by week four and showed a higher degree of BMI 
change from admission to discharge. The AN subtypes did not differ in terms of 
autonomous or controlled motivation for treatment at admission or week four. These 
results are presented in Table 13. 
Discussion 
AN is a serious and often deadly mental health disorder (Steinhausen, 2002, 
Sullivan, 2002), with consistently high reported rates of ambivalence and low motivation 
for treatment (Colton & Pistrang, 2004; Marzola et al., 2015; Reid et al.,2008; Serpell et 
al., 1999; Vitousek et al., 1998; Williams & Reid, 2010 ), as well as high rates of 
premature treatment termination, relapse, and poor outcome reported across treatment 
studies (Fassino et al., 2009; Guarda, 2008; Steinhausen, 2002; Watson & Bulik, 2013). 
Given the clear need to improve treatment outcome in AN patients, researchers and 
clinicians must develop a deeper understanding of the factors that impact treatment 
adherence and outcome in this population. Two potentially important factors that have 
not received a lot of research attention are working alliance and motivation to change. 
Therefore, the present study sought to shed light on these issues by examining data from 
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a pilot study conducted on an adult AN inpatient/day-patient treatment program in 
Toronto, Ontario between 2010 and 2014. The primary goals of the present study were to 
examine (1) the association between changes in levels of autonomous and controlled 
motivation for treatment and working alliance (at week four), (2) the association between 
autonomous and controlled motivation at baseline and treatment outcome, and (3) the 
association between the patients’ self-reported level of working alliance (at week four) 
and treatment outcome in AN. In addition, a secondary goal was to identify baseline 
predictors of working alliance and autonomous and controlled motivation for treatment 
(at week four), as well as to explore the association between the rate of early weight gain 
during the first four weeks of the program and treatment outcome.  
Statistical analyses supported the first main hypothesis of the present study. It was 
found that changes in level of autonomous motivation for treatment significantly 
predicted the level of working alliance between the patient and the treatment team at 
week four. To our knowledge, the current study is the first to examine this relationship. 
The second main finding was that there was no evidence of a significant association 
between baseline measures of autonomous or controlled motivation and treatment 
outcome. This is in contrast to a previous study which found a significant association 
between baseline autonomous motivation and treatment outcome in AN (Carter & Kelly, 
2015). Finally, contrary to expectations, results from the present study did not find 
evidence of a significant association between working alliance (at week four) and 
premature treatment termination, nor between working alliance (at week four) and 
treatment outcome defined as discharge that occurred after 16 weeks of treatment and 
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with BMI and EDE-Q Global scores at non-clinical levels. This is inconsistent with four 
previous studies that found a positive correlation between measures of working alliance 
and either premature treatment termination or treatment outcome (Gallop et al., 1994; 
Jordan et al., 2017; Sly et al., 2013; Stiles-Shields et al., 2013), but partially supports the 
findings of Brown et al. (2013a; 2014).  
In terms of secondary findings, no significant baseline predictors of working 
alliance at week four nor of motivation for treatment at week four were identified. This is 
consistent with the study by Carter and Kelly (2015) who found that the only baseline 
predictor of motivation for treatment was shame. Shame was not examined in the present 
study. Further, no significant association was found between early gains in weight and 
markers of treatment outcome. Finally, significant differences were found between 
patients diagnosed with AN-BP subtype and patients diagnosed with AN-R subtype in 
their baseline reports of distress and AN symptomatology, their BMI levels and reports of 
working alliance at week four, and their relative weight gain from baseline to discharge.   
These preliminary results, however, may have been affected by a number of 
methodological issues that must be taken into consideration in order to properly 
understand and interpret the results of the study. Each of the present findings, and their 
significance in light of the study’s strengths and limitations, are discussed in detail below.  
Baseline Predictors of Working Alliance and Motivation at Week Four 
Based on the assumption that level of working alliance and motivation for 
treatment would be significant predictors of AN treatment outcome, the present study 
first set out to explore possible baseline predictors of self-reports of working alliance and 
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autonomous and controlled motivation at week four. The predictor variables were 
baseline measures of BMI, EDE-Q, and BSI scores, as well as AN subtype, current age, 
and duration of illness.  
Regarding baseline predictors of working alliance at week four, none of the 
variables considered were found to significantly predict Total WAI scores at week four. 
These results are similar to those reported in more recent studies (Stiles-Shields, 
Bamford, Touyz, Le Grange, Hay, & Lacey, 2016). It is possible to theorize that more 
severe cases of AN could be associated with lower reports of working alliance; the higher 
the severity of AN symptomatology the stronger the egosyntonicity of the symptoms and 
the more likely the conflict between patients and the health workers who advocate for 
change. While no such pattern could be found in the present sample, this could be in part 
due to low statistical power to capture the trend. Another compounding reason for these 
results is the fact that 51% of the sample terminated treatment before measures of the 
working alliance could be gathered. Perhaps these premature treatment terminations 
might have been linked to Total WAI scores, possibly very low ones, which could only 
have been determined with earlier measures of working alliance.  
One unique feature of the present study that could have impacted this analysis is 
that a slightly modified version of the WAI was used. The modified WAI was designed to 
assess the relationship between the patient and “the treatment team”; to date, no other 
study has examined this feature in the treatment of AN. The WAI was originally designed 
for use in individual treatment, where the client was asked to rate their working alliance 
with their individual psychotherapist (Horvath & Greenberg, 1989). The present study 
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required changes to the wording from “therapist” to “the treatment team” to accurately 
reflect the treatment setting. 
This change was not considered to represent a significant departure from the 
intended meaning of the instrument’s items, but it is conceivable that it might have 
resulted in some degree of confusion for the patients in this study, and therefore become 
the cause of possible inaccuracies. Patients might have felt compelled to “average” the 
interactions they had with the various members of the treatment team, perhaps 
experiencing conflict or hostility with some and support or comfort from others; further, 
the pattern of interactions might have been overshadowed by impressions from one or 
two particularly salient interactions, for either a more positive or more negative response. 
This complex array of interactions might have resulted in potentially varying Total WAI 
scores depending on a given patient’s interactions with the various members of the 
treatment team, the way the patient interprets these interactions, and how these 
interpretations are prioritized. Thus, it is possible that the validity of the measurement of 
working alliance might have been affected to some extent by the modifications made to 
this instrument in the present study. It is also possible that the changes made to the WAI 
in the present study may explain discrepancies between the current findings and the 
findings of previous studies on the working alliance in AN.  
Regarding predictors of autonomous and controlled motivation for treatment, after 
controlling for baseline level of motivation for treatment and early weight gain, none of 
the observed variables (baseline measures of BMI, EDE-Q, and BSI scores, as well as 
AN subtype, current age, and duration of illness) were found to significantly predict 
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either autonomous or controlled motivation at week four. These findings are in part 
consistent with the results of Carter and Kelly (2015), who similarly found that baseline 
symptomatology was not predictive of level of autonomous or controlled motivation for 
treatment. These findings, however, seem to be counter-intuitive given the theoretical 
framework of the current study. For instance, higher controlled motivation might be 
found in younger patients, as they might experience more pressure from family members; 
and higher scores of autonomous motivation could be expected in cases were 
symptomatology is more severe, impairing, and distressing.   
 It is possible that these non-significant findings could be related to the unusually 
high mean autonomous motivation scores reported in the current sample, at both baseline 
and week four, and the possible lack of validity of the reports of motivation. These 
factors are explored in more detail within the discussion of motivation as predictor of 
outcome later in this section where it is proposed that motivation scores might have been 
inflated due to the particular circumstances inherent to the start of an intensive treatment 
program. 
Another important factor that could have impacted these analyses is the low 
statistical power inherent in the present study. This study utilized data from a relatively 
small sample due to issues of attrition and sampling that have impacted AN research for 
decades (Fairburn, 2005; Guarda, 2008; Wilson et al., 2007). It is possible therefore that 
the present study may not have had sufficient statistical power to capture subtle 
associations between baseline variables and reports of motivation at week four, given the 
small sample size. Further, the current study had an attrition rate that reached 51% in the 
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first four weeks of treatment, before the patients’ second report of motivation was 
gathered. While this rate of attrition is typical for inpatient AN samples (e.g., Fassino et 
al., 2009), in the present study this might have led to the development of a biased sample 
by the fourth week of treatment; it is possible that the retention of individuals who 
ultimately discontinued treatment early might have lent a higher variability to the sample, 
and higher statistical power to the analyses.  
Did Changes in Motivation for Treatment Predict Working Alliance? 
Given the negative impact that ambivalence towards treatment can have on 
interactions between AN patients and healthcare providers (Carter, Kelly, et al., 2012; 
Vitousek et al., 1998; Warren, et al., 2009), the first goal of the present study was to 
examine the relationship between motivation for treatment and working alliance. There 
has only been one previous study on the treatment of adult AN patients that included 
measures of both motivation and working alliance. However, in that study, only the 
association between these variables and outcome was examined (Sly et al., 2013). In the 
current study, it was shown that early increases in autonomous motivation (from 
admission to week four) significantly predicted higher levels of working alliance at week 
four, after controlling for early weight gain. These results align with those reported by 
Mander et al. (2013) who found that being in the contemplation stage of change was 
positively correlated with measures of working alliance among AN patients whereas 
being in the precontemplation stage of change was associated with a lower working 
alliance. The present results are also consistent with findings reported in other clinical 
populations. For example, in one study, adults treated for alcohol addiction demonstrated 
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a positive association between early motivation for change and subsequent ratings of 
working alliance (Connors et al., 2000). The current findings therefore point to the 
possibility that higher motivation for change at treatment onset, or early increases in 
motivation during the first few weeks of treatment, might facilitate a better working 
alliance with the treatment team.  
The direction of the relationship between motivation and working alliance during 
the first four weeks of treatment is unknown. It is possible that the observed changes in 
autonomous motivation were influenced to some degree by the early development of the 
working alliance between patient and treatment team. For instance, an individual might 
present to treatment with some degree of ambivalence and, through the experience of 
support from the treatment team, as well as exploring the rationales behind the goals and 
tasks of treatment, they might see their autonomous drive for change grow and solidify. 
One strength of the current study is that it involved a longitudinal design that included 
repeated measures over the course of treatment in an attempt to capture the process of 
change. Although this study does not allow firm conclusions regarding the timing or 
direction of these relationships, motivation was measured at baseline and week 4 while 
working alliance was measured at week 4 in order to examine these relationships over 
time. In contrast, a cross-sectional study would involve measures at one time point only.  
It is important to note that the theoretical framework on which Hypothesis 1 was 
based did not make provisions for the high baseline levels of autonomous motivation for 
treatment observed in the present sample. The question of change in autonomous 
motivation from baseline to week four assumes that baseline levels of autonomous 
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motivation would, in general, be lower than later in treatment. This assumption follows 
from the consistently high ambivalence towards treatment reported in the AN literature 
(Starzomska, 2009), and low motivation for treatment that has been observed in AN 
treatment studies (Carter & Kelly, 2015; Sly et al., 2013). In contrast, the sample 
analysed in this study reported very high levels of autonomous motivation at baseline, 
with several individuals reporting the highest possible score, and the average reported 
score in fact decreased slightly by week four. These high levels of autonomous 
motivation reported at baseline might be related to the nature of the population that was 
studied. As this was an inpatient sample, the patients in this study were severely 
underweight and typically medically unstable at the time of admission. Their high 
motivation ratings may possibly reflect a temporary desire to seek respite from the severe 
negative effects of AN, and even fear of death, but not an actual desire for meaningful 
behavioural changes. Given that the directionality of the association in the regression 
analysis indicated that an increase in autonomous motivation from baseline to week four 
predicted reports of higher working alliance, the findings might also suggest that working 
alliance was better developed in cases where patients had more moderate, perhaps more 
realistic, reports of motivation at baseline. There was no significant association between 
early changes in controlled motivation and working alliance at week four, thus providing 
support for this statement as well. While controlled motivation has been conceptualized 
as a construct detrimental to effective AN treatment (Carter & Kelly, 2015; 
Vansteenkiste, Soenens, & Vandereycken, 2005), its association with working alliance 
may not be so clear-cut, perhaps due to the methods used to measure this form of 
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motivation. For instance, items such as “I want others to see that I can follow treatment” 
or “I want my therapist to think that I am a good patient”, two items on the CMTQ, may 
be endorsed strongly by patients who appreciate the bond they share with the treatment 
team and might be representative of a positive experience in therapy. Further research 
may be necessary to better elucidate the construct of controlled motivation and its impact, 
if any, on the development of the working alliance in the treatment of AN.   
Did Baseline Motivation for Treatment Predict Treatment Outcome? 
Despite the often negative consequences and risk of death associated with AN 
(APA, 2013; Arcelus et al., 2011; Gaudiani et al., 2012; Baker et al., 2000; Caseiro & 
Frishman, 2006; Takakura et al., 2006; Turner & Shapiro, 1992), the disorder has 
demonstrated a resistance to treatment (Hay et al., 2012; Steinhausen, 2002), with high 
rates of treatment attrition reported across treatment studies (Guarda, 2008; Kaye et al., 
1999). A possible reason for the reported difficulties in successfully treating AN, may lie 
in the largely egosyntonic features of the disorder, which have been widely associated 
with a general lack of motivation for change and strong ambivalence towards engaging in 
treatment (Starzomska, 2009). Thus, a second goal of the present study was to assess 
whether motivation for treatment would predict treatment outcome. 
In contrast to Hypothesis 1, the results provided no evidence of a significant 
association between baseline autonomous motivation and outcome or between changes in 
the level of autonomous motivation from baseline to week four and outcome. These 
findings support those reported by Sly et al. (2013) who found no association between 
baseline measures of motivation, nor shifts in motivation from baseline to week four, and 
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treatment outcome in their AN sample.  The findings also partially support the results of 
Thaler et al. (2016) who also reported that baseline autonomous motivation for treatment 
had no association with treatment outcomes in regard to BMI, but was associated with a 
decrease in AN symptomatology. However, the present study does not align with results 
from Carter and Kelly (2015) who found that early reports of autonomous motivation for 
treatment predicted measures of outcome in a sample composed of individuals 
undergoing treatment for various eating disorders. Their sample, however, included a 
significant proportion (30.9%) of individuals diagnosed with bulimia nervosa (BN); when 
considering only the patients with AN, the authors found no correlation between 
measures of autonomous motivation and discharge BMI, although their sample size 
lacked statistical power. Contrasting with the overall results of Carter and Kelly (2015), 
the results of the present study suggest that the adult AN population may be qualitatively 
different from the BN population in regard to the impact of autonomous motivation on 
treatment outcome. 
While the lack of evidence for Hypothesis 2 may be explained by low statistical 
power in the current study, this factor could be overshadowed in this particular instance 
by the atypical response patterns reported by the sample. The present study reported, 
overall, very high levels of autonomous motivation for treatment, both at baseline and at 
week four; while the average levels of autonomous motivation were slightly decreased at 
week four, this difference was not statistically significant. Such high levels of 
autonomous motivation run contrary to what would be expected of this population in 
light of previous research. One key feature of the AN presentation is the egosyntonicity 
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of the symptoms, which renders severe weight loss and associated behaviours desirable 
and positive from the perspective of the patient. From this viewpoint, treatment aimed at 
weight gain and decreasing compensatory behaviours normally becomes a conflict that 
threatens the patient’s sense of self. Thus, it would be expected, given the theoretical 
framework, that AN patients would report low autonomous motivation or, at best, 
ambivalence. 
In the current sample, mean autonomous motivation was 36.29 at baseline, with 
40% of the sample reporting a score of 40 or higher and 12 individuals reporting the 
highest possible score of 42. This distribution of scores suggests the possibility of a 
ceiling effect regarding the measurement of autonomous motivation. The small decrease 
in scores at week four could be explained by a statistical regression to the mean, as such 
high scores are more likely to show a negative change over time. While these high scores 
are inconsistent with the theoretical expectation, they could be explained by a number of 
factors. One such factor could be that patients did not have a complete understanding of 
their true sense of motivation. It is possible that, seeing themselves at the start of a 
committed intensive treatment, under perceived pressure from families or health workers, 
they might have experienced an inflated sense of autonomous motivation. Perhaps a 
strong belief in an artificially high level of autonomous motivation was required to make 
the decision to start treatment, although this motivation may not be stable enough to 
withstand the demands of treatment, a pattern commonly observed in the field of physical 
conditioning (Sperandei, Vieira, & Reis, 2016). The reports of high autonomous 
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motivation might therefore be an overestimation if the challenges of treatment prove to 
be too high and result in early attrition or low treatment gains (Guarda, 2008). 
Another possible factor that might have influenced the observed high levels of 
autonomous motivation for treatment at baseline could be that patients were simply not 
honest in their reporting. It is possible that AN patients might have felt compelled to 
report higher levels of autonomous motivation than they actually experienced to 
minimise conflict with family or the health care team and to facilitate a peaceable 
treatment process. It is not uncommon for individuals in this population to rush through 
inpatient or day treatment with self-imposed compliance for a prompter return to 
unsupervised life, where they can return to their egosyntonic, symptomatic behaviours 
(Guarda, 2008).  
Ultimately, these findings suggest that autonomous motivation for treatment may 
not be a valid and reliable marker of true treatment engagement and, therefore, of 
treatment success, in the adult AN population. A possible method to explain these results 
may be to consider autonomous motivation as only one dimension of the complex 
ambivalence that individuals diagnosed with AN consistently report regarding treatment 
(Vitousek et al., 1998). While the individual might express an intellectual understanding 
of, and agreement with, a given treatment, they might simultaneously also harbour a 
desire or drive to sustain their AN symptomatology. Expecting that autonomous 
motivation should predict outcome considers motivation as a single dimension, wherein 
an individual can report motivation, or lack thereof, to a given degree. A model of 
ambivalence could add a second dimension to provide insight on the degree to which the 
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individual is also motivated to sustain their illness, presenting a clearer picture of the 
pattern of motivation for and against treatment. Perhaps such a model might lead 
researchers to find markers with higher predictive values of actual commitment to 
change.   
At baseline, the sample reported moderate to high levels of controlled motivation 
for treatment and there was a very slight increase in the level of controlled motivation at 
week four, which was not statistically significant. These findings are in line with previous 
finding on adult AN patients in the literature. Individuals in this population often report 
experiencing external pressures from family, friends, and health care professionals to 
decrease their disordered eating and compensatory behaviours, and to regain a healthy 
weight; in many cases, AN patients enter treatment at the behest of close relations 
(Vitousek et al., 1998). The current study did not find an association between baseline 
levels of controlled motivation for treatment nor early changes in this construct with 
markers of treatment outcome, mirroring the results found by both Carter and Kelly 
(2015) and Thaler et al. (2016). 
In the present study, the reported levels of controlled motivation at baseline were 
somewhat lower than the levels of autonomous motivation. Perhaps the participants were 
better able to assess the pressure they felt from external sources in a more objective or 
balanced fashion. Further, it is possible that a high level of controlled motivation might 
impact reports of autonomous motivation; an individual might feel compelled to present 
as highly motivated if they find themselves under a high external pressure to succeed. 
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However, there is no evidence of an association between the variables of autonomous and 
controlled motivation.   
Regarding the overall findings in relation to controlled motivation for treatment, 
and together with the findings of Carter and Kelly (2015) and Thaler et al. (2016), it is 
possible to theorize that controlled motivation, as a construct distinct from autonomous 
motivation, may show its own associations, and lack thereof, with clinical variables in 
AN. The presence of high levels of controlled motivation, representing external pressures 
to complete treatment, may not indicate the absence of autonomous motivation and vice 
versa.  In the present study, controlled motivation did not predict clinical characteristics 
or outcome variables. It is possible that controlled and autonomous motivation for 
treatment might interact in particular ways in their impact on treatment. Perhaps 
controlled motivation interacts to some extent with the patient’s personality traits in order 
to have a negative or positive impact on treatment. For instance, endorsing items such as 
“I want others to see that I can follow treatment” or “I don’t want other people to be 
disappointed in me”, two items of the CMTQ, may be interpreted differently if endorsed 
by a patient who feels responsible for maintaining a positive, supportive relationship with 
their family than if endorsed by a patient who perceives their environment to be highly 
critical and demanding; the first might experience controlled motivation as a way to feel 
inspired to work on self-development, while the second might experience it in a reactive, 
anxious, or resentful way. Further research is needed to clarify the construct of controlled 
motivation, its valid measurement, and the mechanisms through which it might impact 
mental health.  
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Did Working Alliance Predict Treatment Outcome? 
The working alliance, developed between patient and therapist, has been found to 
be one of the strongest predictors of treatment outcome across a multitude of 
psychological disorders in numerous studies (Horvath et al., 2011, Martin et al., 2000), in 
particular, when measured early in treatment (in the first third of treatment or between 
sessions 1 through 5; Horvath, 2001). Previous research has also suggested that working 
alliance may predict premature treatment termination in an array of mental health 
disorders (Sharf et al., 2010), whereas this association might remain questionable in AN 
treatment (Brown et al., 2013a). Given these findings, the current study anticipated that 
working alliance at week four would predict treatment outcome markers such as changes 
in BMI and AN symptomatology from baseline to discharge, as well as the rate of 
attrition.  
The sample in the present study reported a moderate average level of working 
alliance with the treatment team at week four. A review of the WAI subscales revealed 
that the scores were rather evenly distributed between the three subscales (agreement on 
tasks, agreement on goals, and therapeutic bond). This minimal variability suggests that 
patients were fairly consistent across their reports on the three subscales. The current 
study did not find a significant association between working alliance and outcome nor 
premature treatment termination, and the third hypothesis could therefore not be 
confirmed. These results run contrary to the findings in the general literature on working 
alliance, which consistently highlights the working alliance as one of the principal 
predictors of outcome in treatment of a large majority of mental health disorders 
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(Horvath et al., 2011; Martin et al., 2000). The results of the present study may, therefore, 
lend support to the theory that working alliance may function differently in the treatment 
of AN than in the treatment of other disorders.   
It is important to remember that the present study was based on data from a 
relatively small sample and therefore the present study may not have had sufficient 
statistical power to capture subtle associations between working alliance and outcome. 
Further, the current study had an attrition rate that reached 51% in the first four weeks of 
treatment, before the patient’s reports of working alliance with the treatment team were 
gathered. This rate of attrition is typical for inpatient AN samples (e.g., Fassino et al., 
2009). Thus, those who completed the working alliance measure may have been a biased 
sample in that they may have been more motivated for treatment. This theory is 
supported by the fact that shifts in motivation to change predicted working alliance in the 
current study; however, between-groups t-tests revealed no significant differences in 
baseline reports of autonomous or controlled motivation for treatment between the 
subsample analyzed in this study and those who terminated treatment before four weeks 
of treatment. The rate of early treatment termination may also have been a factor in the 
observed lack of association between the working alliance, outcome, or attrition. Perhaps 
the majority of the people who terminated treatment prematurely would have reported 
lower working alliance thereby contributing to more variance in the data and increasing 
statistical power.  
The role of the working alliance in adult AN treatment remains unclear (Zaitsoff 
et al., 2015). To date, six studies have examined the relationship between working 
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alliance and treatment outcome in the adult AN population. Of note, the present study is 
the first one to measure the working alliance between the client and “the treatment team”, 
rather than an individual therapist. Three of these studies focused on clinical outcome 
(Brown et al., 2013a; Brown et al., 2014; Stiles-Shields et al., 2013). Stiles-Shields et al. 
(2013) examined the relationship between working alliance and treatment effectiveness in 
a sample of adult AN patients receiving outpatient treatment. In this study it was found 
that only measures of working alliance administered toward the end of treatment 
predicted BMI and AN symptomatology at discharge, while mid-treatment measurements 
did not. Brown et al. (2013a) studied the relationship between early working alliance and 
treatment outcome in a sample of adult and adolescent outpatients, with working alliance 
measured at week six (with an overall treatment average of 44 weekly sessions) and at 
discharge. The authors reported no association between early measures of working 
alliance and weight change or the probability of early treatment termination. The results 
of the present study also support the finding that early-to-midpoint measures of the 
working alliance might not be accurate predictors of treatment outcome. In contrast, 
Brown et al. (2014) reported that early weight gain and not working alliance was 
associated with treatment outcome. However, Brown and colleagues assessed working 
alliance using a survey of clinicians who were asked to report on their experience 
working with AN patients, rather than examining the patients’ perspective. Thus, 
methodological differences may explain the discrepant findings. 
The other three studies focused on the association between working alliance and 
treatment dropout (Gallop et al., 1994; Jordan et al., 2017; Sly et al., 2013). These studies 
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found a significant relationship between working alliance and premature treatment 
termination in adult AN patients when the working alliance was measured earlier in the 
course of treatment. In the first, Gallop et al. (1994) found that higher working alliance 
during the third week of treatment was associated with a greater likelihood of treatment 
completion. Sly et al. (2013) found similar results when working alliance was measured 
in the first week of treatment. In addition, Jordan et al. (2017) reported that lower mean 
scores of working alliance, measured throughout the first five sessions, were associated 
with a higher probability of premature treatment termination. Brown et al. (2013a) also 
included an analysis of attrition but, in contrast with the literature, found no association 
between reports of working alliance at week six and early treatment termination. In 
alignment with the findings of Brown and colleagues (2013a) the results of the present 
study did not indicate a significant association between measures of working alliance and 
length of stay in treatment, and therefore do not support the findings of several previous 
studies. A possible explanation for this discrepancy might be that the time point during 
the course of treatment that was selected to measure working alliance in the present 
study, week four of treatment, might not have been an optimal time point to capture an 
accurate representation of this construct. This time point was originally selected to allow 
enough time for the reliable development of working alliance between the patients and 
the treatment team. However, it is possible that working alliance must be assessed before 
(or after) the fourth week of treatment in order to obtain a more accurate measure of the 
variable. In addition, the process of developing a working alliance with a treatment team 
may be different than developing a working alliance with a single therapist. Further, as 
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suggested by the findings of Stiles-Shields et al. (2013) and Brown et al. (2013a), the 
average individual with AN might require longer than four weeks to develop a degree of 
working alliance that could be accurately captured by the WAI.  
Another possible scenario to explain the discrepant results across studies might be 
differences in the treatment setting. As mentioned earlier, previous research has found 
associations between working alliance and subsequent treatment outcome/attrition in the 
treatment of adults with AN (Gallop et al., 1994; Jordan et al., 2017; Sly et al., 2013; 
Stiles-Shields et al., 2013). Two of these studies were conducted with outpatient 
populations (Jordan et al., 2017; Stiles-Shields et al., 2013), while two were conducted on 
inpatient populations (Gallop et al., 1994; Sly et al., 2013). It is possible that working 
alliance with the treatment team, in an intensive treatment setting and with such an 
ambivalent population as AN patients, might fluctuate over time. The intensive treatment 
setting requires daily interactions with various members of the team and therefore 
provides more opportunities for relational conflict and reparation between distressed, 
ambivalent patients and recovery-oriented health professionals; much more than that 
expected in the common weekly appointments for other mental health concerns. It is 
possible to conceive that such variety of interactions might cause the ratings of working 
alliance to oscillate to some degree, perhaps significantly, from one week to the next.  
Similarly, Gallop et al. (1994) and Sly et al. (2013), while studying an inpatient 
population, included multiple measurements of working alliance in their research design 
over the course of treatment whereas the current study measured working alliance only 
once at week four. Having such a design allowed the researchers to better determine a 
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timepoint at which measurements of working alliance were associated with premature 
treatment termination. Therefore, it is conceivable that the present research might have 
captured this association had it included earlier measurements of working alliance, 
perhaps as early as week one. Such repeated measures might shed light on how working 
alliance develops over time in AN intensive treatment, and to what degree it fluctuates at 
the various times of measurement. It could also help researchers determine if there is a 
single ideal time when levels of working alliance would be associated with outcome, or 
allow them to average the various time measurements to find more reliable values. On the 
other hand, the AN inpatient population tend to be a medically and psychiatrically 
unstable population and it is important to consider participant burden in designing clinical 
studies. 
Another important factor to consider in relation to the reliability of the working 
alliance levels reported by the present sample is the changes in the wording of the items 
that were used to measure working alliance for this study. Perhaps one way to obtain a 
more accurate measure of working alliance with the whole treatment team would be to 
ask participants to complete a WAI questionnaire for each one of the individual members 
of the team. Having this detailed information could allow researchers to investigate if 
outcome is associated with the overall impression of working alliance, measured as an 
average of all the individual Total WAI scores provided by a given patient, or if it is 
associated with any given individual WAI scores, perhaps the most salient, extreme 
reports. It should be noted that the practical and logistical limitations of an inpatient 
treatment program, as illustrated in the current study, may render this particular 
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methodology unfeasible. This was the design employed by Gallop et al. (1994), which 
might have accounted for their findings of a positive correlation between averaged scores 
of early measures of working alliance and treatment completion in their sample. Jordan et 
al. (2017), Sly et al. (2013), and Stiles-Shields et al. (2013) might have circumvented this 
issue by selecting the relationship developed with one primary caregiver (e.g., key-nurse) 
as the subject of evaluation.   
One final factor to consider regarding the reliability and validity of the working 
alliance reports is the fact that patients might not have been completely accurate in their 
ratings. Given that the WAI is a self-report measure, it is limited by the awareness the 
subject has on the measured construct and their willingness to share information freely. 
The present study used a coded-identifier data collection approach by researchers who 
were not part of the treatment team to mitigate the possible effects of social desirability 
that may hinder the patients honest responding. Alternatively, the design employed by 
Jordan et al. (2017), which based the evaluation of the working alliance on the 
assessment by blind observers, could also serve to overcome this potential limitation. 
Did Early Weight Gain Predict Treatment Outcome? 
While researchers have reported working alliance to be a strong predictor of 
outcome in different mental health disorders (Horvath et al., 2011; Martin et al., 2000), 
some researchers have hypothesised that perhaps the traits inherent to the AN 
presentation and their impact on treatment might render patients’ reports of working 
alliance a less accurate predictor of treatment outcome than in other populations (Brown 
et al., 2013b). It has been suggested that an alternative predictor of outcome could be 
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found in measures of weight gain early in treatment (Brown et al., 2013b; Hartmann, 
Wirth, & Zeeck, 2007; Turner, Bryant-Waugh, & Marshall, 2015). Based on this 
theoretical framework, some researchers have suggested that AN treatment might be 
more effective if it was focused on gains in weight rather than developing the working 
alliance early in treatment. Thus, an additional goal of the present study was to examine 
the relationship between early weight gain and outcome in adult AN treatment. To 
explore this proposition, the present study included analyses of early weight gain 
(baseline to week four) in its association with outcome. The results indicated no 
association between degree of early weight gain and premature treatment termination, 
changes in BMI from baseline to discharge, or changes in AN symptomatology from 
baseline to discharge. These findings do not support the argument that early weight gain 
should be prioritized over the development of working alliance in AN treatment.  
The present findings partially support the results reported by Sly et al. (2013), 
who observed no association between early weight gain and final treatment outcome, but 
did report an association between early weight gain and premature treatment termination.   
However, as previously mentioned, a lack of statistical power might have prevented the 
analyses of the present study from capturing more subtle associations between the 
variables. Hartmann et al. (2007) reported that weight changes in weeks three and four 
significantly predicted treatment outcome, in contrast to the results of the present study. 
This difference might be explained by differences in the time frames used for weight 
change across studies – admission to week four in the present study versus weeks three 
and four in the Hartmann et al. study; the pooling of weight gain throughout the first four 
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weeks of treatment might have homogenized the scores for the present study, perhaps 
obscuring varying outcomes between weight gain during the first two weeks and the 
second two weeks of treatment. In addition, Hartmann et al. (2007) excluded individuals 
with a BMI higher than 16kg/m
2 
from their sample; individuals with lower BMI are 
expected to have, on average, a more drastic weight change during treatment. The current 
study included several patients with BMI between 16kg/m
2 
and 18.5kg/m
2
; these patients 
require a relatively smaller weight change for successful treatment completion and 
discharge. It is possible that their inclusion might have obscured the impact of early 
weight gain on outcome by adding a level of variability not present in the sample used by 
Hartmann et al. (2007). Elsewhere, Brown et al. (2014) reported that early focus on 
weight gain had a positive association with gains in weight during treatment, whereas 
early focus on working alliance was associated with poorer treatment outcomes. The 
discrepancies between those findings and the present research might be explained by the 
methodological differences between the two studies. First, the study samples were 
different. Whereas the present data were collected from an inpatient unit, Brown et al. 
(2014) conducted their study in an outpatient setting. Another difference was the 
assessment method used. Brown et al. surveyed outpatient clinicians yielding indirect 
data from a variety of sources and treatment characteristics, which was acknowledged by 
the authors as a limitation. In contrast, the current study assessed patient self-reports of 
working alliance. 
Further, some researchers have suggested that early weight gain might in fact 
predict measures of working alliance (Brown et al, 2013a; Xu & Tracey, 2015). While 
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the present study did not state a hypothesis in this regard, an exploratory analysis using 
the present sample did not find evidence to support such a claim. The results of the 
present study showed that early weight gain from admission to week four, as a marker of 
symptom change in AN, did not significantly predict the level of working alliance at 
week four. This suggests that the association between early symptom change and 
working alliance in AN may be different than in other mental health populations and 
perhaps even other eating disorders (Tasca & Lampard, 2012; Turner et al., 2015). The 
findings are in contrast to those of Brown et al. (2013a), who reported that weight change 
predicted subsequent measures of working alliance after six weeks of treatment and 
between the sixth week of treatment and discharge. Brown et al. conducted their study 
with an outpatient sample who met with a single therapist for approximately one hour per 
week, a setting and modality quite different from the inpatient/day treatment, clinical 
team-based approach that is the basis of the present study. This suggests that he impact of 
early weight gain on the working alliance might be impacted by treatment setting and 
modality. While further research is needed to clarify these findings, it is important to note 
that the inconclusive results of this analysis might also be the consequence of low 
statistical power. 
Differences Between AN Subtypes 
The DSM-5 distinguishes two subtypes in AN; restricting subtype (food 
restriction in the absence of binging or purging; AN-R) and bingeing/purging subtype 
(requiring bingeing and/or purging behaviours in addition to food restriction; AN-BP). 
The AN literature further describes a number of clinical features that seem to vary 
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according to the AN subtype. Patients diagnosed with AN-BP often present a higher level 
of impulsivity and distress (Rosval, Steiger, Bruce, Israel, Richardson, & Aubut, 2006; 
Vervaet, van Heeringen, & Audenaert, 2004; Wallier et al., 2009), may be more likely to 
terminate treatment prematurely (Elbaky et al., 2014; Fassino et al., 2009; Woodside et 
al., 2004), and might require a longer course of treatment (Støving et al., 2012; van Son 
et al., 2010). Patients diagnosed with AN-R have been reported to present a 
comparatively lower BMI (Vervaet, et al., 2004). Thus, the present study sought to 
examine whether any differences could be observed in the sample between AN subtypes 
in terms of baseline characteristics, such as age and duration of illness, and clinical 
variables, such as rate of treatment completion, number of weeks in treatment, and 
clinical measurements at various time points.  
In comparison with the AN-BP subgroup, the AN-R subgroup reported 
significantly less distress and lower eating disorder symptomatology at baseline, as well 
as significantly higher WAI Global scores at week four. There were no significant 
differences in either autonomous or controlled motivation at baseline or week four 
between the AN subtypes. Both groups showed a significant decrease in ED 
symptomatology during treatment, with no significant differences between the two 
subgroups regarding changes in EDE-Q Global scores from baseline to discharge.  
Regarding BMI and changes in BMI during treatment, the AN-R subgroup had a 
comparatively lower mean BMI at baseline, but reported a significantly higher weight 
gain over the course of treatment. These findings can be explained when considering two 
factors; the first factor is that the AN-R subgroup started treatment with a relatively lower 
WORKING ALLIANCE, MOTIVATION, AND ANOREXIA NERVOSA 
 
83 
 
mean BMI than the AN-BP subgroup; the second factor is that the majority of the sample 
completed treatment and treatment is considered complete once a patient has reached a 
BMI above 18.5, creating a de facto upper limit for BMI. It follows that, given that 
patients will be discharged when they reach a healthy BMI, those who started treatment 
with a lower BMI are required to make comparatively greater gains. One encouraging 
implication of these results is the suggestion that a lower BMI (i.e., a more severe AN 
presentation) did not preclude the participants in this sample from making clinically 
significant gains. Further research with larger samples is necessary to determine the 
generalizability of these findings.  
Regarding rates of premature treatment termination, participants diagnosed with 
AN-BP showed a trend towards greater rates of attrition with 33% of these individuals 
discontinuing treatment early in contrast with 12% of AN-R patients. While this 
difference between the subtypes approached statistical significance when analyzed in the 
final sample, a post-hoc analysis of the complete initial sample (i.e., including drop-outs) 
revealed a statistically significant difference. A similar pattern was found when 
comparing the two subtypes in terms of baseline BMI; namely, while the analysed final 
sample showed only a trend, a post-hoc analysis of the complete initial sample revealed 
that AN-R participants had significantly lower BMIs at baseline. These findings have two 
important implications. First, the present findings are consistent with the literature on AN 
subtypes, showing that individuals diagnosed with AN-BP show a significantly greater 
rate of attrition from treatment than do individuals diagnosed with AN-R (Elbacky et al., 
2014; Fassino et al., 2009; Woodside et al., 2004) and that individuals diagnosed with 
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AN-R tend to present with lower BMIs than AN-BP patients. Second, this illustrates how 
the research on AN commonly tends to be limited by small sample sizes.  
Overall, AN-BP patients in the current study presented as more symptomatic and 
distressed at the beginning of treatment, in line with the findings reported by Wallier et 
al. (2009). At week four, AN-BP patients reported a lower working alliance with the 
treatment team, although at this point they had achieved a higher average BMI than the 
AN-R subgroup. At time of discharge, AN-BP subgroup appeared to be less able to profit 
from treatment as they presented a higher percentage of premature termination and 
significantly higher symptomatology. A possible explanation for these differences may 
lie in the combination of behavioural and psychological features often observed in each 
AN subtype. AN-BP patients may experience significantly more distress than their 
counterparts because, in addition to a strong egosyntonic desire for weight loss, they have 
to cope with impulsive eating behaviours in direct conflict with their ultimate weight-loss 
goals. This constant struggle between two opposite poles may lead AN-BP patients to 
experience higher psychological distress than AN-R patients, whose behaviour is more in 
line with their egosyntonic drive for weight loss and may serve as a distress deterrent. 
This single-minded commitment to egosyntonic weight loss may also explain the 
significantly lower BMI observed in the AN-R subgroup at baseline.  
To further highlight the differences observed between the subgroups, it is 
important to look at how the treatment presents differential challenges to each AN 
subtype. The treatment methodology would require AN-BP patients to reduce their pre-
established coping behaviours (i.e., purging). It could be expected that this approach 
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would appear more challenging to AN-BP patients, causing a significant rift between the 
members of this AN subgroup and the treatment team, as suggested by the lower reports 
of working alliance at week four. In contrast, AN-R patients may be able to use their 
strong levels of persistence as a strength to adhere to the goals of treatment. This 
difference in the levels of impulsivity between the AN subtypes may also account for the 
higher rates of attrition observed in the AN-BP subgroup.  
The pattern of differences observed in this study between AN subgroups 
regarding clinical variables suggests that AN-R and AN-BP present marked distinctions 
that may have important implications for treatment. These differences might indicate that 
the same treatment might not be optimal for both AN subtypes, whereas the currently 
predominant CBT intensive approach might elicit more beneficial outcomes in AN-R 
patients, the AN-BP population might require a treatment tailored to the particular 
features of their AN presentation. This latter group, for instance, might possibly benefit 
from a treatment that is initially less intensive, and fosters a more gradual decrease of 
their unhealthy coping mechanism. Such a treatment might dedicate more efforts at the 
start of treatment in the development of the working alliance. It is possible that a 
treatment approach that presents more lenient expectations at the start of treatment might 
help address initial levels of distress and increase treatment engagement and retention. In 
line with this premise, researchers are increasingly advocating that medical, 
psychological, and motivational factors need to be considered beyond a single diagnosis 
in order to make more effective decisions around clinical treatment (Geller, Coelho, 
Srikameswaran, Lam, Iyar, & Norris, 2017). 
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Clinical Implications 
Several findings of interest resulted from the present pilot study. Notably, the 
results of the current study, coupled with the results of Sly et al. (2013), suggest that it 
might be of clinical interest to monitor working alliance earlier than week four, perhaps 
starting as early as the first week of treatment, when working with adult AN patients. 
While a number of studies have tried to elucidate the relationship between working 
alliance and outcome, there is no evidence that measurements taken at week four are 
associated with treatment success (Sly et al. 2013). However, researchers reported that 
measures of working alliance taken before week four may show associations to outcome 
and attrition (Gallop et al. 1994; Jordan et al., 2017; Sly et al., 2013; Stiles-Shields et al., 
2013). It is therefore worthwhile to assess levels of working alliance in the initial stages 
of treatment to give clinicians the opportunity to address concerns in the relationship in 
order to improve the probability of treatment success or mitigate potential attrition.  
Alternatively, another possible clinical implication might exist given that the 
present study did not find a significant association between working alliance and 
treatment outcome as measured by BMI at discharge or early treatment termination. 
While the working alliance is an important aspect of psychological treatment, this lack of 
findings might suggest that clinicians working with the AN population might not need to 
prioritise the development of the working alliance over other treatment factors, as this 
might not necessarily determine the risk of early treatment termination and may not be a 
defining factor of successful treatment outcome. However, given the preliminary nature 
WORKING ALLIANCE, MOTIVATION, AND ANOREXIA NERVOSA 
 
87 
 
of the results and the low power of the current study, it would be premature to place 
significant confidence on the lack of findings in this regard. 
Regarding motivation, the current findings also demonstrate, contrary to the 
expectations of the theoretical framework of AN, that this population can report rather 
high levels of autonomous motivation at commencement of treatment. Given the overall 
low rates of treatment success and high rates of attrition found in the present sample, 
aligning with the AN literature at large (e.g., Fassino et al., 2009; Steinhausen, 2002), the 
results suggest that clinicians working with this population should approach self-reports 
of motivation with a degree of caution. While autonomous motivation remains an 
important factor to engage in intensive treatment, the data suggests that it may not be a 
sufficient marker in the prediction of treatment success.  
Based on the results of the present study, one aspect of autonomous motivation 
might yet act as a facilitator of the treatment process. The current findings suggest that 
early increases in motivation were associated with higher ratings of working alliance. 
While the causal directionality of this association cannot be reliably determined at this 
time, these results suggest that helping AN patients explore ambivalent thoughts and 
develop self-directed reasons to dedicate effort in treatment, perhaps using Motivational 
Interviewing or similar techniques, might encourage them to develop a better working 
relationship with clinicians while in treatment. Alternatively, these results could suggest 
that clinicians looking to help AN patients develop their autonomous motivation for 
treatment may be well served by improving their working alliance. Perhaps dedicating 
WORKING ALLIANCE, MOTIVATION, AND ANOREXIA NERVOSA 
 
88 
 
time early in treatment to building an empathic bond and a trusting rapport with AN 
patients might allow for the opportunity to resolve some degree of ambivalence.  
One important clinical implication of the findings of this study is the clinical 
salience of AN subtype; therefore, clinical teams should be strongly encouraged to 
emphasize the correct identification and diagnosis of the AN subcategory. Among the 
differences observed in the current study between AN-R and AN-BP patients is the 
markedly higher rates of early termination and lower reports of working alliance with the 
treatment team found in patients diagnosed with AN-BP. Having this important 
information may allow clinicians to better identify and monitor patients at a higher risk of 
premature treatment termination, perhaps assessing the possibility of dedicating time to 
building the working alliance or exploring treatment ambivalence with these patients. 
Perhaps due to the coexistence of highly opposed drives and beliefs, AN-BP patients also 
reported a markedly higher level of distress and eating disorder symptomatology at 
baseline. The treatment of these patients might be enhanced by a more gradual approach 
that is informed by a close monitoring of their distress levels. Without this consideration, 
and given the statistically higher degree of impulsivity that research has consistently 
observed in the AN-BP population (Rosval et al., 2006; Vervaet et al., 2004), the 
probability of attrition for these patients might be increased. 
Strengths and Limitations 
Strengths. The current pilot study had a number of strengths. Notably, it is the 
first in the AN literature to examine the associations between motivation for treatment 
and working alliance in this population. While other studies have included these 
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constructs, to date, none have investigated the link between motivation and working 
alliance. Given the prominence of working alliance as a predictor of outcome in the 
treatment of a large variety of psychological ailments, the search for factors that impact 
working alliance is an asset to our understanding of AN treatment. Another strength of 
the present study is that it had a longitudinal design that investigated treatment process 
variables over time, as well as predictors of treatment outcome. Psychological treatment, 
as a process of change, is highly dynamic and in a constant state of flux. It is very 
important to learn more about how clinical factors develop over time during 
psychological treatment and few other research studies have assessed these changes and 
their impact on the course of treatment in adult AN. The current study is further enhanced 
by repeated measures in several variables of interest. This allows for a more detailed 
understanding of the progression of clinical change throughout the duration of treatment. 
Another important strength of the present pilot study is that is used well-validated and 
widely used measures. One such feature is the selection of the Working Alliance 
Inventory (WAI) to measure the relationship between the patients and the treatment team. 
The WAI is the most widely utilized instrument in the working alliance literature and its 
use in this study allows for more valid and reliable comparison of the results with other 
similar research in the literature.  
 An additional strength of the current study is the fact that it collected a wide 
variety of demographic and clinical data including the patients’ diagnostic subtype. This 
allows for the analysis and report of the contrast between the AN subgroups in an 
unprecedented diversity of variables, from baseline characteristics, to their particular 
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response to treatment, to their differences in treatment outcome. The results of the present 
study can therefore add important information regarding the differences and similarities 
between the AN subtypes. Most importantly, the information obtained through this 
method might help researchers elucidate how each subgroup responds to treatment, 
potentially leading to the development of clinical methods that more suitably tailored to 
the particularities of each diagnostic subcategory.  
Limitations. The current study methodology also had a number of limitations. 
First, there was a high drop-out rate. The issue of attrition has widely plagued research 
studies on AN. As noted by Halmi et al. (2005), there are a number of reasons for this 
including the egosyntonic nature of the disorder, which can act to positively reinforce 
unhealthy behaviours, and the possible function of AN symptoms as a coping 
mechanism. In the current study, working alliance was measured after four weeks to 
allow the patients to adjust to the intensive treatment environment and develop a degree 
of working alliance with the treatment team. However, out of the 108 patients who agreed 
to participate in the study, only 53 remained in treatment long enough to provide data on 
the variables of interest, presenting an initial attrition rate of 51%.  A comparison of 
patients who dropped out and patients who remained in treatment revealed no significant 
differences at baseline providing no evidence that the analysed group was statistically 
biased. However, it is possible that they were different in some way not measured in this 
study. The sample size was further reduced by additional attrition that occurred after the 
fourth week of treatment that limited the data available for certain variables, namely 
eating disorder symptomatology as measured by EDE-Q Global scores at discharge.  
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This illustrates the practical challenges of the real-life scenario of a patient 
arriving at the decision of terminating their involvement in an intensive treatment 
program. While they might come to this decision impulsively or in a moment of crisis, it 
might prove to be a practical impossibility to ask them to complete a battery of self-report 
questionnaires at that time. Fortunately, this is not the case for the other variable used as a 
marker of outcome, namely the patients BMI. As their body weight was measured 
regularly during treatment, their last measurement was used to calculate BMI at time of 
discharge.  
The level of attrition in the current study has an important implication for 
interpreting the results. Of note is the decrease in statistical power and the confidence that 
can be placed on the results. Working with such a small sample may prevent the various 
statistical analyses capturing significant associations between variables and changes over 
time. This posits a particular challenge in the present study given that most analyses 
resulted in non-significance; a study that included a larger sample may yet reveal a true 
significant association between the constructs that were investigated. A second 
implication is that changes in symptomatology could only be conducted on what could be 
considered a bias sample, namely those who completed treatment. This is problematic 
because, as the AN literature highlights, this is not indicative of population norms 
(Guarda, 2008; Kaye et al., 1999). A large portion of individuals that meet the criteria for 
AN will not seek treatment or will discontinue treatment early (Guarda, 2008; Keski-
Rahkonen et al., 2007; Watson & Bulik, 2013). The results of the analyses conducted on 
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such a biased sample should therefore not be generalized to the adult AN population at 
large.  
The results of the present study are correlational and therefore do not imply 
causality. Thus, it cannot be stated with certainty that an increase in autonomous 
motivation resulted in higher levels of working alliance in the current sample. While 
early changes in autonomous motivation for treatment were found to predict working 
alliance at week four in the present research, the methodology in place does not allow for 
a clear determination of whether changes in motivation are the cause of the subsequent 
reported levels of working alliance. Although the measurements of autonomous 
motivation precluded the measurement of working alliance, in practice motivation and 
working alliance were being developed simultaneously since the beginning of treatment, 
perhaps influencing each other. The inability to ultimately distinguish the directionality 
of the association is a limitation that stems from the single measurement of working 
alliance that only occurred at week four to allow time for the patients to develop a 
relationship with the treatment team. The methodology used in this study would be 
improved by the addition of earlier measures of working alliance. Past research in the 
field of working alliance has found that valid measures of this construct could be 
obtained as early as the first week of treatment (Martin et al., 2000; Sly et al., 2013). The 
results of the current study may have benefited from reports of working alliance at weeks 
one, two, and three. This could serve as an improvement in two ways; first, it would 
maximize the information gathered from the initial sample, possibly increasing statistical 
power and shedding light on the characteristics of individuals who decide to terminate 
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treatment prematurely; second, a longitudinal, repeated-measures research design would 
allow a more complete understanding of how the working alliance develops over time in 
the adult AN population and how it is associated to markers of outcome. Future research 
using multiple measures of working alliance over the course of treatment is needed.  
The use of self-report questionnaires to measure levels of working alliance and 
motivation might also represent a limitation in the present study. In the case of WAI 
scores, it is possible that the patients’ experience of the working alliance varied across 
time, and the single measurement of the construct may not be an accurate representation 
of the constructs true values. Regarding the measurement of motivation, the level of 
autonomous motivation observed at baseline in the present sample was unusually high. 
Given that the AN population often presents as highly ambivalent towards treatment and 
that the ACMTQ offers no validity scales to judge the sincerity of a patient’s response, it 
is conceivable that such high reports might be inaccurate. It is also possible that 
autonomous motivation might be easily overestimated in self reports and may ultimately 
fail to act as a predictor of treatment outcome in populations that are consistently 
ambivalent towards treatment. The development of ACMTQ norms for the AN 
population could help researchers determine how normative the given response may be. 
One final limitation that should be acknowledged is that this was a single sample 
cohort design and there was no control group. This is another common limitation in the 
research involving the AN population, as it is ethically challenging to assign individuals 
diagnosed with such a life-threatening disorder to control groups involving no treatment 
or treatment that is less than optimal. 
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Directions for Future Research 
Having described the limitations, and strengths of the present project as well as 
the possible clinical implications, this final section addresses possible future research 
directions. A number of possible avenues for future research have emerged from the 
current study. First, future researchers should consider very early measurements of 
working alliance when working with this population, especially when focusing on 
predictors of outcome. The present study failed to capture a significant link between 
measures of outcome and reports of working alliance when taken at week four of 
treatment while previous studies have obtained statistically significant results when 
reports of working alliance were gathered prior to the fourth week of treatment. Next, it 
will be important to determine the validity of self-reports of autonomous motivation in 
AN patients, and perhaps explore the significance of a model of ambivalence in this 
population in the prediction of treatment outcome. Contrary to the hypotheses in the 
present study reports of autonomous motivation did not necessarily correlate or predict 
more positive outcomes suggesting that perhaps autonomous motivation is not sufficient 
to explain the outcomes of treatment. Finally, future research may need to explore the 
clinical validity of the AN subtypes in the review of a unified clinical treatment that is 
prescribed for both. In the present study, AN subtype immerged as a significant predictor 
of attrition and of working alliance in alignment with several reports in the literature 
suggesting that the two subtypes may present different responses to treatment.   
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Time of working alliance measures. Researchers attempting to study working 
alliance in the adult AN population, in particular when searching for predictors of 
outcome, should consider measuring working alliance in the initial weeks of treatment  
The present study did not find an association between measures of working alliance at 
week four and treatment outcome, whereas previous studies that reported significant 
associations between working alliance and dropout rates have focused on single or 
multiple measurements of working alliance as early as week one (Gallop et al., 1994; 
Jordan et al., 2017; Sly et al., 2013). It is yet to be determined if there is one optimal time 
point at which working alliance is most predictive of outcome or if multiple 
measurements in the initial phases of treatment would best capture the construct as a 
predictor; further research is need in this regard. Future researchers should note that 
measurements of working alliance in adult AN patients, when taken too late, might be 
affected by early attrition characteristic of the population, potentially decreasing the 
predictive capabilities of the construct.  
Validity of self-reports of autonomous motivation. One important area for 
future AN research endeavours is further determining the validity of self-reports of 
autonomous motivation and their impact, if any, on treatment. In the current study, 
contrary to the low levels of motivation generally reported of patients in the AN 
literature, the present sample reported high autonomous motivation and yet, while it was 
found to be predictive of working alliance measures at week four, it was not associated 
with treatment outcome. Future AN treatment studies should investigate the possible 
interactions between initial level of motivation and other related variables, such as 
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commitment to treatment or self-efficacy, in order to better understand motivation for 
treatment in AN. Alternatively, researchers exploring autonomous motivation in the AN 
population may be well served by adopting a model that not only accounts for the self-
motivated drives that an AN patient might report at the beginning of treatment but that 
also expands into an exploration of the egosyntonic reasons for which the patient may be 
inclined to sustain their AN symptomatology. A model of ambivalence that accounts for 
both autonomous motivation for treatment and autonomous motivation to maintain illness 
may prove to be more informative and provide better insight into the drives of AN 
patients. Perhaps the consideration of this “motivation to sustain illness” as a factor in 
future regression models might help elucidate the possible association between 
motivation for treatment and outcome. This approach would require the development of a 
measure for autonomous motivation to maintain illness, which could be designed to 
address the particular features of the AN presentation.     
AN subtypes. Finally, a topic of interest that may implicate the AN literature at 
large and a worthwhile subject for future research is the qualitative differences that 
appear to exist between the AN subtypes. In the current study, the AN subgroups differed 
in their reports of working alliance, baseline levels of distress and eating disorder 
symptomatology, as well as rate of treatment completion. These findings echo the results 
of similar research in the AN literature, indicating the stability of these differences. When 
coupling this set of observations with the larger literature on eating disorders, where 
qualitative differences are found between AN patients and bulimia nervosa (BN) patients 
in presentation and response to treatment, it is reasonable to argue that it might be of 
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benefit to subject the ED classifications to an in-depth review. Currently, the DSM-5 
(APA, 2013) classifies individuals with an eating disorder under the diagnosis of AN if 
their BMI is below 18.5 kg/m
2
 regardless of their method of weight control; those who 
primarily restrict their eating would receive a diagnosis of Other Specified Feeding or 
Eating Disorder (OSFED), Atypical Anorexia Nervosa if their BMI is above 18.5 kg/m
2
 
and a diagnosis of AN, restricting subtype if their BMI is below this cut-off; those who 
primarily binge and purge receive a diagnosis of BN above the BMI cut-off and a 
diagnosis of AN binge-purging subtype below the BMI cut-off. What this represents is a 
classification system that combines two qualitatively different presentation into a single 
diagnostic umbrella based on a horizontal cut-off; a BMI below 18.5 kg/m
2
. The 
existence of the AN subtypes acknowledges these differences. The fact that both 
presentations fall under the same diagnostic umbrella, however, might act as a potential 
limitation in research and as a potential detriment for AN treatment. In AN research, 
pooling treatment data from two qualitatively different diagnoses may result in confounds 
that obscure the significance of treatment effects and other related variables, which could 
potentially account for the mixed findings reported in the AN literature to date. In AN 
treatment, pooling two populations with significantly different presentations into a single 
treatment method might yield uneven or inconsistent treatment outcomes, which could 
account for the low rates of treatment effectiveness and high rates of attrition in the AN 
population. It is possible to conceive that patients diagnosed with AN-BP may have more 
in common with BN patients than AN-R patients. Such a hypothesis would be better 
represented by a diagnostic conceptualization in which the AN-BP presentation is 
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understood as a more severe form of BN and diagnostically differentiated from AN-R. 
What this would represent is a classification system that brings to the forefront a vertical 
division between the presentations. Researchers in the field of AN treatment should be 
encouraged to report findings making an emphasis on AN subtypes to further build our 
understanding of the differences between the groups. Ultimately, research endeavours 
should be dedicated to clarify which classification model would be most helpful for 
research in eating disorders in general, and AN in particular, in order to maximize the 
effectiveness of treatment methods, thus finding more consistent means to help a 
population suffering from great distress and facing a very dangerous outcome.   
Conclusion 
In summary, the treatment of adult AN remains one of the most paramount 
clinical endeavours while continuing to be elusive to develop and investigate due in great 
part to the very characteristics that define this serious disorder. The present pilot study 
explored the working alliance and motivation for treatment as clinical factors that might 
help predict treatment outcome in adult AN, and was the first research study to explore 
the link between working alliance and motivation for treatment in this population. While 
no association was found between working alliance and treatment outcome, nor between 
motivation for treatment and treatment outcome, the present study found that baseline 
measures of autonomous motivation, and early changes in this variable, predicted reports 
of working alliance at week four of treatment. While several limitations commonly found 
in the study of AN populations reduced the inferences that can be derived from these 
findings, the data suggests that perhaps a model of ambivalence towards treatment might 
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be more informative in this population than the one-sided study of motivation for 
treatment. Further, the current study found that AN subtypes seemed to differ in their 
response to treatment, the quality of their working alliance with the treatment team, and 
differed significantly in measures of treatment outcome and rates of early treatment 
termination. These findings add to the body of research that suggests AN subtypes, 
binging-purging and restricting, might present enough qualitative differences to warrant 
the consideration of different treatment approaches. In addition to this question, future 
research must further assess the time at which measures of working alliance should be 
taken to maximize their predictive capabilities and ascertain the validity of self-reports of 
motivation for treatment. Continued effort must be sustained in clinical research to 
improve the efficacy of the treatments to mitigate this distressing and life-threatening 
mental illness that affects so many individuals and families.  
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Figures 
Figure 1 
Flow Chart of Sample Size and Attrition 
 
  
108 Consecutive Patients 
Recruited for Study 
55 Patients Terminated Treatment 
Before the Measurement of 
Working Alliance 
53 Patients Remained in Study 
with Measurements of Working 
Alliance 
40 Patients Completed Treatment 
36 Patients Provided EDE-Q 
Scores at Discharge 
25 Patients in the Attrition Group 
Completed Measures of Motivation 
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Tables 
Table 1 
Marital Status, Living Circumstances, Current Occupation, and Ethnicity of Sample 
(N=53) 
  Frequencies (%) 
Marital Status   
Single  37 (69.8) 
Married  10 (18.9) 
Separated  2 (3.8) 
Divorced  1 (1.9) 
Common-law  2 (3.8) 
Missing data  1 (1.9) 
Living Circumstances   
Lives alone  11 (20.8) 
Lives with parents  24 (45.3) 
Lives with partner/children  12 (22.6) 
Lives with friends/roommates  4 (7.5) 
Lives with other family  1 (1.9) 
Missing data  1 (1.9) 
Current Occupation   
Higher executives, proprietors, major professionals  2 (3.8) 
Business managers, medium size business, lesser 
professional 
 
4 (7.5) 
Administrative, owners, small business, minor 
professionals 
 
7 (13.2) 
Clerical/sales workers, technicians, owner little 
business 
 
2 (3.8) 
Skilled manual employees  3 (5.7) 
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Unskilled  4 (7.5) 
Student  15 (28.3) 
Unemployed  10 (18.9) 
Self-Employed  1 (1.9) 
Community and social service occupation  3 (5.7) 
Missing data  2 (3.8) 
Ethnicity   
Caucasian (White)  35 (66.0) 
French Canadian  1 (1.9) 
West Indian  1 (1.9) 
Oriental  1 (1.9) 
Italian  4 (7.5) 
East Indian  1 (1.9) 
European  4 (7.5) 
Canadian  2 (3.8) 
Irish  1 (1.9) 
Dutch  1 (1.9) 
Missing data  2 (3.8) 
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Table 2 
Age, Age at Onset, Duration of Illness, and Weeks in Program of Sample (N=53) 
   Mean (SD) 
Current age   30.00 (10.43) 
Age at onset   19.63 (8.58) 
Duration of illness (years)   10.67 (9.60) 
Weeks in program   15.74 (5.46) 
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Table 3 
Frequencies of Eating Disorder (ED) Diagnosis , Previous Intensive Treatment, and 
Program Completion (N=53) 
   Frequency (%) 
ED diagnosis    
AN-R   24 (45.3) 
AN-BP   29 (54.7) 
Previous intensive treatment for ED    
No   28 (52.8) 
Yes   24 (45.3) 
Missing data   1 (1.9) 
Program completion    
Did not complete program   13 (24.5) 
Completed program   40 (75.5) 
Note. AN-R = Anorexia Nervosa, Restricting subtype; AN-BP = Anorexia Nervosa, Bingeing/Purging 
subtype. Program completion defined by an EDE-Q total < 4 and BMI > 18.5 at time of discharge. 
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Table 4 
Results of Paired t-test Comparing Means of BMI, EDE-Q, BSI, AMTQ, and CMTQ 
Scores at Baseline, Week 4, and/or Discharge 
 Baseline Week 4 Discharge    
 
Mean 
(SD) 
 
n 
Mean 
(SD) n 
Mean 
(SD) n 
 
t 
 
df 
Cohen’s 
d 
EDE-Q 4.38 
(1.47) 
53 –  2.90 
(1.51) 
36 7.052
*** 
35 1 
BSI 2.21 
(.84) 
52 –  1.31 
(0.85) 
36 6.570
*** 
34 1.06 
AMTQ  36.29 
(5.70) 
52 31.32 
(7.17) 
52 –  .797 50 .76 
CMTQ 31.33 
(7.17) 
52 31.94 
(6.57) 
52 
– 
 -.541 50 .09 
BMI 15.01 
(1.33) 
53 16.00 
(1.42) 
53 n/a  8.394
***
 52 .74 
 15.01 
(1.33) 
53 n/a  19.65 
(1.55) 
53 20.052
***
 52 3.22 
Note. BMI = Body Mass Index; EDE-Q = Eating Disorder Examination Questionnaire; BSI = Brief 
Symptom Inventory; AMTQ = Autonomous Motivation for Treatment questionnaire; CMTQ = 
Controlled Motivation for Treatment questionnaire. “–” indicates that no data were collected at the time. 
“n/a” indicates that the data was not included in the respective t-test analysis. 
***
p < .001. 
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Table 5 
Results of Independent Samples t-tests Comparing Means of Baseline Demographic 
and Clinical Variables Between the Analyzed Sample and Attrition Subgroup 
 Analyzed 
Sample 
Mean (SD) 
Attrition 
Subgroup 
Mean (SD) t df Cohen’s d 
Age 30.01 (10.43) 29.69 (11.52) -.153 106 .03 
Duration of Illness  11.05 (9.58) 10.09 (9.76) -.500 101 .09 
T1 BMI 15.05 (1.32) 14.80 (1.50) -.757 105 .17 
T1 BSI 2.20 (.83) 2.21 (.78) .085 106 .01 
T1 EDE-Q 4.38 (1.47) 4.64 (1.10) .769 76 .20 
T1 AMTQ 36.65 (6.09) 35.16 (7.34) -.926 74 .22 
T1 CMTQ 31.32 (7.16) 31.70 (7.74) .210 74 .05 
Note. BMI = Body Mass Index; BSI = Brief Symptom Inventory; EDE-Q = Eating Disorder 
Examination Questionnaire; WAI = Working Alliance Inventory; AMTQ = Autonomous Motivation for 
Treatment questionnaire; CMTQ = Controlled Motivation for Treatment questionnaire; T1 = Baseline; 
duration of illness was measured in years. 
All t-tests are non-significant. 
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Table 6 
Results of the Hierarchical Regression Analyses with WAI at Week 4 as the Criterion 
and changes in BMI, AMTQ, and CMTQ, from Baseline to Week 4, as the Predictors 
(N=51) 
 B SE B β t 
Model      
1     
T1-W4 BMI (1) 2.534 1.667 .212 1.520 
T1-W4 AMTQ (2) -.882 .257 -.438 -3.439**
 
2     
T1-W4 BMI (1) 2.534 1.667 .212 1.520 
T1-W4 CMTQ (2) -.317 .251 -.176 -.265 
Note. WAI = Working Alliance Inventory; BMI = Body Mass Index; AMTQ = Autonomous Motivation 
for Treatment questionnaire; CMTQ = Controlled Motivation for Treatment questionnaire; T1-W4 = 
Baseline to Week 4 change. Numbers in brackets indicate the step in which each variable was added.  
**
p < .01. 
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Table 7 
Results of the Hierarchical Regression Analyses with Baseline (T1) to Discharge (T2) 
BMI Change as the Criterion 
 B SE B β t 
Model      
1 (N=52)     
AN subtype (1) -.884 .446 -.270 .053 
T1 AMTQ (2) -.002 .037 -.007 -.053 
2 (N=52)     
AN subtype (1) -.884 .446 -.270 .053 
T1 CMTQ (2) .029 .031 .124 .908 
3 (N=51)     
AN subtype (1) -.739 .435 -.236 -1.700 
T1-W4 AMTQ (2) .016 .044 .053 .367 
4 (N=51)     
AN subtype (1) -.739 .435 -.236 -1.700 
T1-W4 CMTQ (2) .051 .038 .184 1.339 
5 (N=53)     
AN subtype (1) -.974 .449 -.290 -2.168
*
 
W4 WAI (2) -.013 .024 -.076 -.528 
6 (N=53)     
AN subtype (1) -.974 .449 -.290 -2.168
*
 
T1-W4 BMI (2) .382 363 .195 1.450 
Note. BMI = Body Mass Index; AMTQ = Autonomous Motivation for Treatment questionnaire; CMTQ 
= Controlled Motivation for Treatment questionnaire; WAI = Working Alliance Inventory; W4 = Week 
4. Numbers in brackets indicate the step in which each variable was added.  
*
p < .05. 
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Table 8 
Results of the Hierarchical Regression Analyses with Baseline (T1) to Discharge (T2) 
EDE-Q Change as the Criterion (N=36) 
  B SE B β t 
Model       
1       
AN subtype (1)  -.353 .373 -.160 -.945 
T1 AMTQ (2)  .010 .034 .050 .289 
2       
AN subtype (1)  -.353 .373 -.160 -.945 
T1 CMTQ (2)  .028 .026 .182 1.078 
3       
AN subtype (1)  -.353 .373 -.160 -.945 
T1-W4 AMTQ (2)  .004 .039 .020 .111 
4       
AN subtype (1)  -.353 .373 -.160 -.945 
T1-W4 CMTQ (2)  .012 .034 .062 .359 
5      
AN subtype (1)  -.353 .373 -.160 -.945 
W4 WAI (2)  -.023 .020 -.211 -1.153 
6       
AN subtype (1)  -.353 .373 -.160 -.945 
T1-W4 BMI (2)  .031 .229 .024 .136 
Note. EDE-Q = Eating Disorder Examination Questionnaire; AMTQ = Autonomous Motivation for 
Treatment questionnaire; CMTQ = Controlled Motivation for Treatment questionnaire; WAI = Working 
Alliance Inventory; BMI = Body Mass Index. W4 = Week 4. Numbers in brackets indicate the step in 
which each variable was added.  
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Table 9 
Results of the Hierarchical Logistic Regression Analyses with Treatment Dropout as 
the Criterion (N=53) 
 B SE Wald 
Model     
1    
AN subtype (1) 1.304 .730 3.187 
W4 WAI (2) -.035 .036 .939 
2    
AN subtype (1) 1.304 .730 3.187 
T1-W4 BMI (2) -.210 .431 .238 
Note. WAI = Working Alliance Inventory; BMI = Body Mass Index; W4 = Week 4; T1 = Baseline. 
Numbers in brackets indicate the step in which each variable was added.  
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Table 10 
Results of the Hierarchical Regression Analyses with AMTQ at Week 4 as the Criterion 
and Baseline Variables as the Predictors (N=51) 
 B SE B β t 
T1 AMTQ (1) .567 .125 .578 4.544 
T1-W4 BMI (1) .442 .844 .067 .523 
T1 BMI (2) -.543 .565 -.123 -.961 
AN subtype (2) -1.468 1.624 -.128 -.904 
Age (2) .119 .082 .221 1.446 
Duration of illness (2) -.065 .093 -.104 -.699 
T1 EDE-Q (2) -.225 .837 -.058 -.269 
T1 BSI (2) .091 1.482 .014 .062 
Note. AMTQ = Autonomous Motivation for Treatment questionnaire; CMTQ = Controlled Motivation 
for Treatment questionnaire; BMI = Body Mass Index; EDE-Q = Eating Disorder Examination 
Questionnaire; BSI = Brief Symptom Inventory; T1 = Baseline; W4 = week 4; T1-W4 = Baseline to 
Week 4 change. Numbers in brackets indicate the step in which each variable was added.  
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Table 11 
Results of the Hierarchical Regression Analyses with CMTQ at Week 4 as the Criterion 
and Baseline Variables as the Predictors (N=51) 
 B SE B β t 
T1 CMTQ (1) .547 .106 .605 5.141 
T1-W4 BMI (1) .264 .824 .038 .320 
T1 BMI (2) -.681 .619 -.146 -1.100 
AN subtype (2) -.097 1.813 -.008 -.053 
Age (2) .014 .091 .024 .150 
Duration of illness (2) .037 .102 .056 .358 
T1 EDE-Q (2) -.051 .917 -.012 -.056 
T1 BSI (2) 1.043 1.643 .147 .634 
Note. AMTQ = Autonomous Motivation for Treatment questionnaire; CMTQ = Controlled Motivation 
for Treatment questionnaire; BMI = Body Mass Index; EDE-Q = Eating Disorder Examination 
Questionnaire; BSI = Brief Symptom Inventory; T1 = Baseline; T2 = Discharge; W4 = week 4; T1-W4 = 
Baseline to Week 4 change. Numbers in brackets indicate the step in which each variable was added.  
 
 
  
WORKING ALLIANCE, MOTIVATION, AND ANOREXIA NERVOSA 
 
138 
 
Table 12 
Results of the Hierarchical Regression Analyses with WAI at Week 4 as the Criterion 
and Baseline Variables as the Predictors (N=51) 
 B SE B β t 
T1-W4 BMI (1) 2.202 1.663 .186 1.324 
T1 BMI (2) -.387 1.067 -.049 -.363 
AN subtype (2) -4.980 3.059 -.244 -1.628 
Age (2) .283 .157 .288 1.802 
Duration of illness (2) -.283 .170 -.257 -1.665 
T1 EDE-Q (2) -2.167 1.576 -.309 -1.375 
T1 BSI (2) .579 2.842 .048 .204 
Note. WAI = Working Alliance Inventory; BMI = Body Mass Index; EDE-Q = Eating Disorder 
Examination Questionnaire; BSI = Brief Symptom Inventory; T1 = Baseline; W4 = week 4; T1-W4 = 
Baseline to Week 4 change. Numbers in brackets indicate the step in which each variable was added.  
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Table 13 
Results of Independent Samples t-tests Comparing Means of BSI, EDE-Q, WAI, AMTQ 
and CMTQ Scores, as well as BMI, by AN Subtypes 
 AN subtype  
 AN-R 
Mean (SD) 
AN-BP 
Mean (SD) t df Cohen’s d 
T1 BSI 1.74 (.82) 2.61 (.64) -4.261
*** 
50 1.18 
T1 EDE-Q 3.70 (1.66) 4.96 (1.02) -3.380
*** 
51 .91 
T1 BMI 14.65 (1.33) 15.32 (1.27) -1.858 51 .51 
T2 BMI 19.82 (1.53) 19.52 (1.58) .717 51 .19 
W4 BMI 15.49 (1.40) 16.43 (1.32) -2.471
* 
51 .69 
T1-W4 BMI .85 (1.06) 1.11 (.65) -1.101 51 .29 
T1-T2 BMI 5.17 (1.57) 4.19 (1.68) 2.168
* 
51 .60 
W4 WAI  42.67 (9.33) 35.48 (9.82) 2.711
**
 51 .75 
T1 AMTQ 36.00 (6.82) 37.21 (5.45) -.713 50 .20 
T1 CMTQ 31.08 (7.25) 31.54 (7.23) -.225 50 .06 
Note. AN-R = Anorexia Nervosa, Restricting subtype; AN-BP = Anorexia Nervosa, Bingeing/Purging 
subtype; BMI = Body Mass Index; BSI = Brief Symptom Inventory; EDE-Q = Eating Disorder 
Examination Questionnaire; WAI = Working Alliance Inventory; AMTQ = Autonomous Motivation for 
Treatment questionnaire; CMTQ = Controlled Motivation for Treatment questionnaire; W4 = Week 4; 
T1 Baseline; T2 = Discharge; T1-W4 = Baseline to Week 4 change; T1-T2 = Baseline to Discharge 
change. 
*
p < .05. 
**
p < .01. 
***
p ≤ .001. 
 
 
